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“The bigger difficulty  
was the speech. Hugo’s palate was operated on just 
after his first birthday. He became an immensely 
chatty toddler. From the age of about one and a half, 
he developed an obsession with cars, … The first one 
he learned was Mini, which he could say more or less 
perfectly. But others were less readily 
comprehensible. BMW was a strange concoction of 
vowels and glottal stops, unrecognizable to all but his 
parents; Honda was “Onna”; Porsche was “Orrs... So 
just before he was three, Hugo had a third operation, 
to elongate his palate; and then, six months later, he 
had another, more minor one. For the past two years, 
he has had regular speech therapy…”  
 
 William Sckidelsky. The Guardian, 2015 
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The clinic has been the greatest source of inspiration to propose 
and conduct this research project. In October 2015, an article 
about the experience of a parent having a child with cleft lip and 
palate was published in the British newspaper ‘The Guardian’ (see 
quote text left page). In this article, I clearly recognize many 
problems that I encounter daily. Therefore, I will use this story to 
take you along the introduction of this thesis.  
Cleft lip and/or palate (CL/P) is the most common congenital 
facial malformation in humans. Every three minutes a child with an 
orofacial cleft (deformity) is born, especially in developing 
countries this constitutes a major problem where millions of 
children are suffering from untreated clefts.1 In the Netherlands, 
the incidence of CL/P is 1.6 in 1.000,2 while, in Colombia, it varies 
from 1 in 500 to 1 in 1.000 births.1 CL/P can be associated with 
other anomalies and may be part of a syndrome. Clefts are 
generally divided into two groups based on both genetic and 
embryological grounds; clefts involving the anterior structures (lip 
and primary palate) and clefts involving only the soft palate or 
extending into the hard palate (secondary palate).3-5 Hence CL/P 
is a highly heterogeneous group of disorders affecting the upper 
lip, the nose, and the oral cavity (Figure 1).6 A complete 
description of abnormal and abnormal development of primary 
and secondary palates has been published recently.7 In this 
publication, a new classification for orofacial clefts based on both 
cell biological mechanisms (e.g. fusion and differentiation defects), 
and time in embryonic development is proposed. This new 
method enables more accurate determination of etiology through 
gene identification and/or environmental interactions.7,8 
The treatment of these patients is complex, and involves a 
multidisciplinary team and includes multiple interventions (e.g. 
surgical repair, speech therapy, hearing control/management and 
orthodontic treatment). It starts before birth (prenatal counseling) 
and lasts until early adulthood (Figure 2).9  
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Figure 1. Schematic representation of the oral cavity. The palate separates 
the nasal from the oral cavity. The primary palate (yellow), and secondary 
palate (blue). The secondary palate is divided into a hard bony palate (dark 
blue) and a muscular soft palate (light blue). 
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Figure 2. Unilateral cleft lip and palate. The treatment is complex and 
multiples interventions (e.g. surgical repair, speech therapy, and orthodontic 
treatment) are required. It starts before birth (prenatal counseling) and lasts 
until early adulthood. Adapted from: www.schisisonderzoek.nl 
 
 
 
From the bed … 
 
The palate separates the nasal from the oral cavity. It is divided 
into an anterior bony (hard) palate and a posterior muscular (soft) 
palate (Figure 1). The levator veli palatini (LVP) is the major muscle 
of the soft palate and occupies about 40% of the total length of 
the soft palate.10 It elevates the soft palate and extends 
posteriorly sealing off the pharynx. The LVP is thus crucial for the 
normal functioning of the soft palate during speech, blowing, 
swallowing and sucking. In non-cleft subjects, the LVP originates 
bilaterally at the skull base (petrous portion of the temporal bone) 
and fans out into the soft palate to join its counterpart at the 
midline. In contrast, the fibers of the LVP in patients with cleft lip 
and palate insert into the bony cleft edges and/or posterior edge 
of the hard palate (Figure 3). 
  
CHAPTER 1
16
Figure 3. Muscles of the soft palate. m. tensor veli palatini (TVP), m. levator 
veli palatini (LVP), m. palatoglossus (PG), m. palatopharyngeus (PP), m. 
uvulae (U), and palatal aponeurosis (PA). The dashed line indicates the 
posterior border of the hard palate. Notice the abnormal insertion of the soft 
palate muscles into the posterior border of the hard palate at the cleft side.  
Only after attention was raised for the abnormal insertion of 
palatal muscles, new surgical techniques were developed with the 
aim to reconstruct the levator muscle sling.10-12 Nowadays, muscle 
reconstruction is considered the most critical component of the 
surgical repair of the soft palate.10 Although there is a wide range 
of surgical protocols, soft palate repair generally takes place in 
early childhood13 and aims at optimal function of the 
velopharyngeal sphincter and speech development.14,15 
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The main morbidity associated with a cleft in the soft palate is 
velopharyngeal dysfunction (VPD). This is the general term used to 
describe the inability of the soft palate to achieve complete 
velopharyngeal closure (Figure 4). The velopharyngeal sphincter is 
composed of the soft palate anteriorly, the lateral pharyngeal 
walls, and the posterior pharyngeal wall. Velopharyngeal closure is 
accomplished by the combination of the movement of all these 
structures. The velopharyngeal sphincter should remain open for 
normal breathing and for the production of nasal consonants (/m/, 
/n/, and /ng/). In contrast, complete closure of the velopharyngeal 
sphincter is required for the production of oral pressure 
consonants (e.g. /p/, /b/, /t/, /d/, /k/, /g/, /s/, /z/, /f/, /v/), vowels 
/a/, /e/, /i/, /o/ /u/), sucking, swallowing and blowing (Figure 4).13 
Various patterns of velopharyngeal closure have been described.16  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Lateral view of the airway. N: nasal cavity, O: oral cavity, green: 
posterior pharyngeal wall, dark blue: hard palate, light blue: soft palate, and 
pink: air escapes through the nose when consonants such as "p", "b", "g", 
"t", and "d" are pronounced. This phenomenon is called velopharyngeal 
dysfunction. 
CHAPTER 1
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Despite the wide range of surgical techniques for soft palate 
repair17, about 10 to 30% of the patients is still not able to achieve 
complete velopharyngeal closure after surgery.18,19 This results in 
hypernasal speech (primary effect of VPD) and other functional 
deficits such as nasal escape and articulation disorders that often 
require a second surgical correction in 25% of these patients.18,19 
Furthermore, the child may develop compensatory speech 
patterns (secondary effects of VPD), which can affect his social 
interaction with other children and adults. In fact, more 
adolescents with an operated cleft express concerns about their 
speech than about their facial appearance.20  
VPD can be diagnosed both by subjective and objective means. 
Perceptual evaluation of speech and nasometry by an experienced 
speech therapist remains the standard.21,22 In addition, intraoral 
inspection, videofluoroscopy and nasoendoscopy provide visual 
information of velopharyngeal closure. Speech therapy is thus 
necessary to correct articulation errors while surgery is required to 
correct nasal air escape and hypernasality. The type of surgical 
procedure depends on the preoperative pattern of velopharyngeal 
closure.23 Surgical interventions include posterior pharyngeal wall 
augmentation, redirection of the anteriorly displaced LVP, palatal 
lengthening, sphincter pharyngoplasty and pharyngoplasty.24  
Other problems commonly associated with the surgical closure 
of the soft palate are the formation of oronasal fistula. Oronasal 
fistula have been reported in about 8% of cases when only surgical 
closure of the soft palate is performed.15 Fistula can also lead to 
air escape contributing to the symptoms of hypernasal speech.25 
Facial growth seems not to be affected by closure of the soft 
palate only.26 When a cleft involves both the soft and the hard 
palate a one - or two - stages protocol is used: in the one-stage 
protocol both hard and soft palate are closed at the same time. 
The side effects of this protocol are assumed to include 
disturbances of facial growth. The two-stage protocol consists of 
   INTRODUCTION 
 
19
two separate operations. Soft palate and hard palate are closed at 
different time points. The closure of the hard palate can be 
delayed until the phase of mixed dentition, so around 8-9 years 
old. The claimed advantage of this second technique is that it may 
avoid gross disturbances of facial development. However, a lot of 
controversy remains on the issue of optimal timing. Hence, 
randomized prospective clinical trials are warranted to determine 
the optimal timing of palatoplasty with respect to long-term 
speech development and maxillofacial growth.27 
 
 
 … to biological side 
 
Deficiencies in speech remain frustratingly common in children 
with a history of a cleft in the soft palate. This can have a 
devastating effect on their social interaction with other children 
and adults.20 Several factors may contribute to suboptimal repair 
and hampered speech, such as age at the moment of surgery, 
skills and experience of the surgeon, type and extension of the 
cleft, scar tissue formation, damage of the motor nerve supply of 
the LVP muscle, the muscle fiber type distribution, and impaired 
muscle regeneration.19,28-37 From all these factors, two biological 
aspects drew our attention: first, impaired muscle regeneration 
and second, scar tissue formation in the muscle layer (fibrosis).  
Skeletal muscles possess a remarkable ability to regenerate after 
injury. The progenitor cells that are responsible for muscle 
regeneration are the satellite cells (SCs).38,39 After injury, SCs 
undergo proliferation, differentiation and fusion to form new 
myofibers or repair damaged ones.40,41 Although muscle repair is 
an important component of contemporary palatoplasty, little is 
known about muscle regeneration of the soft palate muscles after 
cleft palate repair. In the presence of excessive collagen 
accumulation, injured muscles heal slowly and often show 
incomplete functional recovery.42 Eventually, suture repair of the 
CHAPTER 1  
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muscle sling can favour healing, but even this does not prevent 
fibrosis.43 Scar tissue formation  in the palatal mucosa has already 
called attention, because of its detrimental effects on maxillary 
growth.44-47 However, the influence of scar tissue on the repaired 
soft palate and on muscle regeneration cannot be underestimated 
since it is probably responsible for impaired muscle function after 
surgical repair of the clefted muscles.  
In the last two decades, several strategies based on tissue 
engineering have been employed to improve muscle 
regeneration. Growth factors, satellite cells, biological and 
synthetic scaffolds or a combination of these have been applied 
with varying results.48-56 Most studies on muscle regeneration, 
however, have been performed on limb muscles, while studies on 
head muscles are scarce. It is important to understand head 
muscle regeneration since accumulating evidence suggests that 
muscles from limb and head muscles differ in several aspects. 
Skeletal muscles from the trunk and limbs are, for example, 
derived from the somites,57 while most head muscles including 
those of the soft palate are derived from the branchial arches.58-60 
Freeze or crush injuries of the head muscles heal much slower than 
similar injuries in limb muscles.61 Moreover, more fibrous 
connective tissue is formed during healing. In addition, SCs from 
head muscles also express a distinct profile of transcription factors 
including unique factors such as Tcf21.62 All this indicates that the 
physiology of SCs from limb and head muscles is different, and 
that they react different to injury.63 Thus, soft palate muscles may 
possess a less effective regenerative response after injury, which 
may be a critical factor in cleft healing after surgery.64  
In summary, both impaired muscle regeneration and scar 
formation (fibrosis) hamper the functional recovery of the soft 
palate muscles after cleft palate repair. Novel therapies based on 
tissue engineering that prevent scar formation and stimulate 
muscle regeneration may improve the functional recovery after 
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surgical repair. These therapies will offer new perspectives for the 
treatment of patients with cleft lip and palate. 
 
 
Let’s start!  
 
To date, adjuvant therapies based on tissue engineering for soft 
palate repair are not available, and a basis for proper translation is 
missing. Therefore, the general aim of this research project was to 
gain knowledge in the understanding of the biology and 
regeneration of branchiomeric–derived muscles. We started with a 
literature review on myogenesis in the non-cleft and cleft palate, 
the characteristics of soft palate muscles, and the process of 
muscle regeneration, which is reported in chapter 2. Also, novel 
therapeutic strategies based on tissue engineering to improve soft 
palate function after surgical repair are proposed. These adjuvant 
therapies are expected to improve the outcome after surgical 
repair by targeting new aspects of muscle healing which were not 
considered before.  
As mentioned earlier, little is known about muscle regeneration 
after surgery. Therefore, a newly in vivo model for the study of 
muscle regeneration in the soft palate of rats is described in 
chapter 3. Subsequently, we investigated the long-term 
regeneration of the soft palate muscles and the formation of 
fibrotic tissue after excisional injury in chapter 4.  
In vitro culture systems that allow the study of SCs from head 
muscles are crucial to develop new therapies based on tissue 
engineering. Hence, in chapter 5, we presented a new protocol for 
the isolation, culture and differentiation of SCs from rat head 
muscles. In chapter 6 we investigated the differences between 
branchiomeric head muscles and limb muscles in rats of two ages, 
and the properties of the SCs. Lastly, principal findings are 
summarized and discussed according to their current scientific 
context in the general discussion presented in chapter 7. 
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Abstract  
Children with a cleft in the soft palate have difficulties with speech, 
swallowing, and sucking. These patients are unable to separate the 
nasal from the oral cavity leading to air loss during speech. 
Although surgical repair ameliorates soft palate function by joining 
the clefted muscles of the soft palate, optimal function is often not 
achieved. The regeneration of muscles in the soft palate after 
surgery is hampered because of (1) their low intrinsic regenerative 
capacity, (2) the muscle properties related to clefting, and (3) the 
development of fibrosis. Adjuvant strategies based on tissue 
engineering may improve the outcome after surgery by 
approaching these specific issues. Therefore, this review will 
discuss myogenesis in the non-cleft and cleft palate, the 
characteristics of soft palate muscles, and the process of muscle 
regeneration. Finally, novel therapeutic strategies based on tissue 
engineering to improve soft palate function after surgical repair 
are presented. 
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Cleft lip and/or palate (CLP) is the most common congenital 
facial malformation in humans. It occurs in about 1/500 to 1/1000 
births, with ethnic and geographic variation.1 This disorder is 
generally divided into two groups: clefts involving the lip with or 
without cleft palate and isolated cleft palate2 (Figure 1). CLP can 
also be part of a syndrome when it is associated with other 
congenital defects.3 In this review we will focus on clefts involving 
the soft palate. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cleft lip and/or palate. (a) Cleft lip. (b) Unilateral cleft lip and palate. (c) 
Bilateral cleft lip and palate. (d) Isolated cleft palate. The dashed line indicates the 
posterior border of the hard palate. 
 
Children with a cleft in the soft palate have difficulties with 
speech, swallowing, and sucking. These patients are unable to 
separate the nasal from the oral cavity; a phenomenon known as 
velopharyngeal dysfunction. Surgical repair is required to close the 
defect and to reconstruct the muscle sling of the m. levator veli 
palatini (LVP), the major muscle of the soft palate4 (Figure 2). It 
ensures optimal function and normal speech development.5,6 
However, about 10% to 30% of the treated patients remain unable 
to achieve adequate velopharyngeal function.7,8 This results in 
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hypernasal speech that often requires additional surgical 
corrections. Diverse factors are attributed to suboptimal repair 
such as age at the time of the surgery, skills and experience of the 
surgeon, type and extension of the cleft, fibrosis, damage of the 
motor and proprioceptive innervation, and abnormal fiber type 
distribution.7,9–12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Muscles of the soft palate. m. tensor veli palatini (TVP), m. levator veli 
palatini (LVP), the major muscle of the soft palate, m. palatoglossus (PG), m. 
palatopharyngeus (PP), m. uvulae (U), and palatal aponeurosis (PA). The dashed 
line indicates the posterior border of the hard palate. Notice the abnormal 
insertion of the soft palate muscles into the posterior border of the hard palate at 
the cleft side. In this area disorganized myofibers are present. Cleft palate 
muscles are limited to isometric contractions and often underdeveloped. 
 
This review will highlight the myogenesis and characteristics of 
the soft palate muscles in the non-cleft and cleft palate, and the 
process of muscle regeneration. We postulate that muscle healing 
and function after soft palate repair can be improved by adjuvant 
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strategies from the field of regenerative medicine. How these 
novel adjuvant strategies based on tissue engineering could 
improve muscle healing and prevent velopharyngeal dysfunction 
after surgical repair will be discussed. 
 
 
Soft palate myogenesis 
 
The muscles of the soft palate and those controlling jaw 
movement, facial expression, and pharyngeal (throat) and laryngeal 
(voice box) function are known as branchiomeric muscles.13,14 The 
formation of the soft palate muscles starts already early in 
embryonic development and yields five pairs of muscles: (1) the 
tensor veli palatini (TVP), (2) the LVP, (3) the palatopharyngeus (PP), 
(4) the palatoglossus (PG), and 5) the uvulae (U) (Figure 2). 
Mesenchymal condensations of the individual soft palate muscles 
emerge sequentially, starting from the sixth week of gestation in 
humans, with the TVP appearing first and the U last. Their full 
morphological development is completed after the 17th week of 
intrauterine life. The hard palate is already fused at this stage. The 
masticatory muscles and the TVP develop at the same time, and 
are followed by the morphogenesis of the LVP, PP, PG, and U 
muscles, and by the palatal aponeurosis (PA).15,16 The development 
of the soft palate muscles in cleft patients is delayed compared 
with non-cleft individuals.17 
 
 
Soft palate muscles in the normal and cleft palate 
 
The soft palate is formed by an interweaving of muscles from the 
skull base (TVP and LVP), tongue (PG), and pharynx (PP; Figure 2). 
All muscles extend from nearby bony structures and are inserted 
into the PA located in the center of the soft palate (Figure 2). 
Hence, all muscles have only one skeletal insertion, with the 
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exception of the U, which is a completely intrinsic muscle of the 
soft palate without bony attachment. In the cleft palate, the 
muscles are attached to the posterior border of the hard palate 
(Figure 2). The abnormal insertions of the muscles, in particular the 
LVP, in cleft palate patients prevent normal functioning. These 
muscles have two instead of one skeletal attachments limiting 
them to isometric contractions.18 As a result, the cleft muscles pull 
the two halves of the soft palate in a superior and lateral direction, 
causing further widening of the cleft.19 In addition, the LVP may 
become severely atrophic because of reduced function, and often 
has only half of the thickness found in healthy newborns. The LVP 
myofibers are also disorganized next to the cleft margin.16,17 
Both slow and fast fibers are present in the soft palate muscles. 
Slow fibers are highly resistant to fatigue, with a low activation 
threshold, whereas fast fibers are more fatigable, with a higher 
activation threshold. In non-cleft individuals, the LVP contains 
predominantly slow fibers,20,21 whereas in cleft individuals it 
contains a higher proportion of fast fibers and a reduced capillary 
supply compared with normal LVP muscles.22–24 A fetal myosin 
heavy chain isoform is also present in a small number of fibers in all 
palatal muscles. In comparison with limb muscles, the individual 
and intramuscular variability in fiber diameter of the LVP is much 
larger.21 The higher number of fast fibers in cleft patients may 
cause the increased fatigability of the LVP during speech,23 which 
contributes to velopharyngeal dysfunction.25 Further, fast fibers are 
more prone to contraction-induced injury.24,26,27 
 
 
Muscle regeneration in the soft palate 
 
After injury. Satellite cells (SCs)28 are the primary muscle stem cells, 
and are responsible for postnatal muscle growth, maintenance, 
and repair. After injury, adjacent SCs become activated and 
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migrate to the site of injury, proliferate, differentiate, and fuse to 
form new myofibers or repair damaged ones.29,30 In addition, 
signaling molecules from infiltrating macrophages, injured 
myofibers, and the disrupted extracellular matrix participate in the 
regeneration process.29–31 The formation of scar tissue may prevent 
proper muscle regeneration.32–34 The majority of studies on muscle 
regeneration have been performed in limb muscles, while studies 
on head muscles are scarce. Muscles from the limbs and the head 
differ in several aspects. Skeletal muscles from the trunk and limbs 
are derived from the somites35 during embryonic development, 
while most head muscles including those of the soft palate are 
derived from the branchial arches.36–38 The masseter muscle, a 
branchiomeric muscle, seems to contain less SCs than limb 
muscle.39 Freeze or crush injuries in the masseter muscle also 
regenerate much slower than similar injuries in limb muscles.40 
Moreover, much more fibrous connective tissue is formed in the 
damaged area. Proliferating SCs from limb and head muscle also 
express a distinct profile of transcription factors.39 In vitro, SC-
derived myoblasts from masseter proliferate more but differentiate 
later than those from limb muscle. Remarkably, both SC 
populations are similarly able to regenerate limb muscle injuries 
after transplantation.39 These observations support the crucial role 
of the SC niche in muscle regeneration.  
As mentioned, fast fibers are predominantly found in cleft palate 
muscles compared with normal soft palate muscles.22–24 In general, 
the percentage of SCs in fast muscle fibers is significantly lower 
than in slow muscle fibers.41,42 This may further decrease the SC 
number in cleft palate muscles. In addition, in vitro studies show 
that SCs from fast muscle fibers proliferate less than those from 
slow muscle fibers.39 In rodent models for muscle atrophy induced 
by disuse, SCs decrease in number and display reduced 
function.43–45 Further, impaired macrophage recruitment to the site 
of injury and impaired macrophage function has been recently 
CHAPTER 2 
 36
demonstrated in this muscle atrophy model.46 A similar situation 
may exist in cleft palate muscles that are limited to isometric 
contractions and are therefore also atrophied. The accompanying 
poor capillary supply may further impair the regeneration process 
and promote fibrosis.18,19 
Disorganized muscle fibers are found at the attachment of cleft 
palate muscles to the posterior border of the palatal bone.16,17 This 
possibly prevents further postnatal myofiber maturation by normal 
function.47  
In summary, the lower regenerative capacity of branchiomeric 
muscles in general, and the specific properties of cleft palate 
muscles may compromise muscle regeneration following surgical 
repair in cleft patients. 
 
 
Soft palate muscles in animal models 
 
Several mammalian species have been used for the study of the 
normal and clefted palate. The most frequently used animal 
models are goats, mice, and rats.48–53 Up to now, tissue 
engineering studies in the soft palate have not been performed. 
Therefore, the selection of an appropriate animal model for the 
study of the regeneration of the soft palate muscles is highly 
important. The use of an existing congenital cleft palate model in 
the goat51,54–56 is not feasible due to the high costs that limits 
group size. Cleft palate models in knockout mice are generally 
limited to embryological studies due to high mortality after birth, 
and lack of reproducibility of the induced clefts.57–60 However, the 
widespread use of rodents for fundamental and preclinical 
research ensures the availability of extensive tools and markers. In 
addition, their low cost and ease of handling make them the most 
suitable model for the development of soft palate muscle 
engineering techniques. 
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Similar to humans, the soft palate muscles in rodents possess a 
mixture of slow and fast fibers,61 and play an important role in 
swallowing and respiration.61,62 In addition, the soft palate muscles 
in cleft animals also run parallel to the margins of the cleft, and 
disorganized myofibers are present.60 In contrast to humans,17 the 
development of the palatal muscles in cleft palate mice is not 
delayed.63 
The advantage of the rat over the mouse is its larger body size 
favoring surgical manipulation of the soft palate. This makes the 
rat the most suitable animal for experimental research on muscle 
regeneration of the soft palate. 
 
 
Tissue engineering to improve the outcome of surgery 
 
As mentioned in the previous sections, several biological factors 
have been attributed to functional impairment of the soft palate 
after surgical correction (Figure 3): (1) Low intrinsic regenerative 
capacity of soft palate muscles. As shown, branchiomeric muscles 
including those of the soft palate, have a low number of SCs with a 
low rate of differentiation compared with limb muscles, which may 
contribute to their poor regenerative capacity. (2) Muscle 
properties related to clefting. Clefted soft palate muscles contain a 
lower number of myofibers and are highly disorganized close to 
the cleft margin. This impedes the function of the reconstructed 
muscle. (3) The development of fibrosis. The main harmful effect of 
surgery is the development of muscle fibrosis, which impairs the 
regeneration of muscle fibers. Strategies based on tissue 
engineering may ameliorate the functional outcome of surgical 
repair by approaching these three main issues. 
Another factor that may influence the regeneration of palatal 
muscles is age. In general, the number of SCs in growing postnatal 
muscle is about 30%–35% of all nuclei.64–66 In adulthood, only 1–4% 
of all nuclei belong to the SC population.67 Surgical repair of the 
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soft palate generally takes place in early childhood (6–36 months 
of age). After birth, the soft palate muscles are still immature. A 
large number of SCs are present to fulfill the demands of growth.68 
In contrast, newborn SCs seem to engraft less efficiently than their 
adult counterparts.69 This should be taken into account when 
developing tissue engineering strategies for soft palate muscles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Muscle problems related to clefting. Before surgery: (1) Low intrinsic 
regenerative capacity: less number of satellite cells with a low rate of 
differentiation, (2) Muscle properties related to clefting: clefted soft palate 
muscles contain lesser number of myofibers and are highly disorganized. After 
surgery: (3) Fibrosis. Adjuvant strategies based on tissue engineering using (stem) 
cells, growth factors, and scaffolds may improve the outcome after surgery. 
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Improving the intrinsic regenerative properties of the soft palate 
muscles 
Isolated SCs may be used for cell-based therapy to improve the 
regenerative capacity of the soft palate muscles. It has been 
demonstrated that transplanted SCs are able to form new 
myofibers and to self–renew.70 This approach has already been 
used for the treatment of a variety of diseases such as muscular 
dystrophy71 and myocardial infarction.72–74 Unfortunately, the 
success of transplantation of SCs and myoblasts has only been 
limited. After isolation, SCs seem to lose their regenerative 
capacity in culture. In addition, their survival and migration to the 
site of injury after injection is limited.75,76 
Mesenchymal and embryonic stem cells can also differentiate 
into skeletal muscle.77–79 However, only a small fraction of cultured 
mesenchymal stem cells undergo fusion into myofibers80 
suggesting that these cells may not be an appropriate cell type for 
therapeutic use.81 Embryonic stem cells have a large potential for 
cell-based therapies for a wide range of diseases.82,83 These cells 
may offer additional advantages such as their larger replicative 
potential, and the possibility to perform gene targeting.84 
However, embryonic stem cell-derived myogenic populations with 
possible therapeutic value have not been found up to now. 
Alternatively, other non-muscle stem cells such as 
mesoangioblasts and pericytes also have myogenic potential.85,86 
Both mesoangioblasts and pericytes can be delivered systemically 
because of their ability to cross the endothelium. This approach 
was successful for cell therapy in muscular dystrophy.86,87 
Nevertheless, the exact ability of non-muscle stem cells for muscle 
regeneration and their possible use in cell therapy remain to be 
elucidated.88–91 
As an alternative approach, the recruitment, proliferation, and 
differentiation of SCs already present in the soft palate muscle may 
be stimulated by specific growth factors. As mentioned, muscle 
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growth and regeneration is controlled by locally-produced growth 
factors, which stimulate SCs such as insulin-like growth factor 1 
(IGF-1) and fibroblast growth factor 2 (FGF-2). IGF-1 favors muscle 
regeneration by increasing the rate of SC proliferation and the 
formation of myotubes.92–96 Similarly, FGF-2 stimulates muscle 
regeneration in vitro and in vivo by promoting the proliferation of 
myoblasts after injury.97–100 Moreover, it facilitates the recruitment 
and proliferation of SCs101 and promotes angiogenesis.102,103 
However, when growth factors are injected in vivo, they rapidly 
lose their biological activity due to diffusion and/or enzymatic 
inactivation.104 Because of this, growth factors and attachment 
motifs have been incorporated into biodegradable scaffolds for 
controlled release.105 With microspheres prepared from materials 
such as polylactic-co-glycolic acid, the release of such factors can 
be controlled.106–108 In addition, fibrin and gelatin hydrogels can 
give a sustained release of (growth) factors.109–112 These new 
techniques may improve the delivery of factors to the site of injury 
and stimulate muscle regeneration. 
Although cell-based therapy seems to be promising for the 
treatment of genetic muscle defects, it is probably not a feasible 
option for cleft palate because it is a completely different type of 
condition. For example, in degenerative diseases like Duchenne 
muscular dystrophy, multiple cycles of muscle degeneration and 
regeneration deplete the SC population.113 In contrast, in cleft 
palate, muscle SCs are preserved. In summary, growth factors and 
cytokines in a suitable delivery system may stimulate proliferation 
and differentiation of resident SCs in the soft palate muscles after 
surgical repair. 
 
Correcting cleft-associated muscle abnormalities 
Muscle is a highly organized structure consisting of long, parallel 
multinucleated myotubes to generate sufficient force for 
contraction.114 Therefore, the random myofiber orientation in cleft 
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palate muscles impedes normal function after surgical repair. The 
reduced function limits the switch from a fast to a slow myofiber 
type.12,24 This may explain the increased muscle fatigability 
observed in patients with velopharyngeal dysfunction.23 
Proper alignment of regenerating myotubes may be achieved 
with scaffolds of specific design and surface topography.115 
Myoblasts are known to respond to the surrounding topography,116 
which leads to directional cell growth.115 Hence, different 
techniques have been described to control cellular alignment on 
micro- and nanostructured surfaces produced either by chemical or 
topographic patterning. These include electrospinning,117 
photolithography,118 and electron beam lithography.119 
Aligned nanofiber meshes can be fabricated from biocompatible 
polymers such as poly-lactide or poly-glycolideco lactide via 
electrospinning.119 Muscle cells cultured in these meshes show 
alignment and migration and a contractile phenotype.120,121 
However, up to now the possibilities to control the mechanical 
properties of these polymer meshes is limited.120 In addition, 
slowly degrading polymers persist in the regenerated tissue for a 
long time. Since the repair of the soft palate is generally 
performed in children, later growth of the soft palate must be 
accommodated. Therefore, the use of rapidly degrading polymers 
seems to be more suitable. Recently, it was reported that growth 
factors can be printed onto sub-micron polystyrene fibers. 122,123 A 
combination of a suitable scaffold with growth factors and 
cytokines (e.g., stromal cell derived factor–1) might favor 
migration,124 differentiation of resident SCs, and induce myofiber 
alignment. 
Particularly in patients with wider clefts, the amount of soft 
palate tissue is limited, which causes tension at the junction of the 
hard and soft palate after surgical repair. It has been proposed 
that scarring affects the length of the soft palate in anteroposterior 
direction,125 which depends on the specific technique used for 
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closure.126 Alternatively, scarring may contribute to a narrowing of 
the residual cleft after two stage palatoplasty.126–128 The site most 
likely to fistulize is at the junction of the hard and soft palate.129 
Fistulae usually have been associated with the type of cleft, 
technique and timing of repair, and the experience of the 
surgeon.130 Substitutes as decellularized dermal allograft have 
been successfully used to close wide defects while preventing 
fistulae formation.131 The use of scaffolds in the soft palate muscles 
allows a defined architecture to guide cell growth and 
development. 
 
Preventing secondary effects of surgery: fibrosis 
The deposition of excess ECM during regeneration may lead to 
fibrosis and impaired muscle function. A key factor in fibrosis is 
transforming growth factor-beta 1 (TGF-1). 132,133 It stimulates the 
synthesis of collagen and other extracellular matrix components 
and promotes myofibroblast formation.134 Myostatin, another 
member of the TGF- family, inhibits muscle regeneration by the 
inhibition of SC and myoblast proliferation.135–138 In this way, TGF-
1 and myostatin synergistically amplify the fibrotic process after 
injury. In contrast, myostatin knockout mice develop less fibrosis 
and display improved skeletal muscle regeneration compared with 
wild-type mice.139 
The inhibition of TGF-1 and myostatin may prevent fibrous scar 
formation and improve muscle healing after injury.139 Decorin is a 
member of the small leucine-rich proteoglycan family, and it 
reduces both TGF-1 and myostatin activity.139–142 It thereby 
enhances the proliferation and differentiation of myogenic cells,143 
and prevents fibrosis.144 In addition, decorin upregulates the 
expression of a variety of myogenic markers including Myf5, Myf6, 
MyoD, and myogenin in vitro.145 Hepatocyte growth factor 
increases decorin production by fibroblasts.146 Furthermore, small 
TISSUE ENGINEERING FOR SOFT PALATE  
 43
signaling molecules such as nitric oxide down regulate TGF1 
activity.147 However, the importance of nitric oxide in muscle 
regeneration must be further elucidated. In summary, the use of 
decorin and other factors that inhibit TGF-1 and myostatin may 
prevent scar formation after surgical correction of the soft cleft 
palate. A disadvantage might be that anti-fibrotic therapy can 
diminish narrowing of the residual cleft after two-stage 
palatoplasty. Therefore, the long-term effects of novel therapies 
based on tissue engineering in such a complex anatomical 
environment is hard to predict. Further research should elucidate 
the final outcome of these new therapeutic approaches 
 
 
Conclusions 
 
This review discusses the development and characteristics of the 
soft palate muscles in the non-cleft and cleft palate and the 
process of muscle regeneration. Finally, tissue engineering 
strategies are proposed to improve muscle regeneration after the 
closure of the soft palate. The regeneration of muscles in the soft 
palate after surgery is hampered because of (1) their low intrinsic 
regenerative capacity, (2) muscle properties related to clefting, and 
(3) the development of fibrosis. We propose the following 
strategies based on tissue engineering, to improve the functional 
outcome after surgical repair. 
To improve muscle regeneration (problem 1), growth factors and 
cytokines might be applied to the surgical wounds by 
incorporation into scaffolds or microspheres. The growth factors 
should enhance SC recruitment from the adjacent muscle tissue 
and their proliferation and differentiation into new myofibers. This 
will enhance the intrinsic regeneration capacity of the soft palate 
muscles, and thereby increase the functional outcome of surgery in 
terms of number and maturation of myofibers. 
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Suitable scaffolds may also support the alignment of myofibers 
and compensate the limited amount of tissue in clefted muscles 
(problem 2). These scaffolds should offer an architecture that 
guides cell growth and myofiber formation. In terms of function, 
this approach will increase muscle volume and force generation by 
the soft palate muscles. 
To prevent fibrosis (problem 3), TGF-1 and myostatin activity 
can be inhibited by factors such as decorin. This will reduce the 
formation of fibrotic tissue and stimulate proliferation of 
myoblasts. The function of the soft palate muscles after repair will 
thus improve by allowing myofiber formation and alignment 
(approaches 1 and 2). 
Wrapping up, scaffolds that give a controlled release of growth 
factors, guide the alignment of new myofibers, and prevent fibrosis 
might improve muscle regeneration after surgical repair of the cleft 
soft palate. Nevertheless, further research is required in order to 
develop these functionalized scaffolds. 
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Abstract 
Children with a cleft in the soft palate have difficulties with speech, 
swallowing, and sucking. Despite successful surgical repositioning 
of the muscles, optimal function is often not achieved. Scar 
formation and defective regeneration may hamper the functional 
recovery of the muscles after cleft palate repair. Therefore, the aim 
of this study is to investigate the anatomy and histology of the soft 
palate in rats, and to establish an in vivo model for muscle 
regeneration after surgical injury. 
Fourteen adult male Sprague Dawley rats were divided into four 
groups. Groups 1 (n=4) and 2 (n=2) were used to investigate the 
anatomy and histology of the soft palate, respectively. Group 3 
(n=6) was used for surgical wounding of the soft palate, and group 
4 (n=2) was used as unwounded control group. The wounds (1 mm) 
were evaluated by (immuno)histochemistry (AZAN staining, Pax7, 
MyoD, MyoG, MyHC, and ASMA) after 7 days. 
The present study sho ws that the anatomy and histology of the 
soft palate muscles of the rat is largely comparable with that in 
humans. All wounds showed clinical evidence of healing after 7 
days. AZAN staining demonstrated extensive collagen deposition 
in the wound area, and initial regeneration of muscle fibers and 
salivary glands. Proliferating and differentiating satellite cells were 
identified in the wound area by antibody staining. 
This model is the first, suitable for studying muscle regeneration 
in the rat soft palate, and allows the development of novel 
adjuvant strategies to promote muscle regeneration after cleft 
palate surgery. 
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Cleft lip and/or palate (CLP) is the most common congenital facial 
malformation in humans. It occurs in about 1:500 to 1:1000 births, 
with ethnic and geographic variation.1 CLP is generally divided into 
clefts involving the lip with or without cleft palate, and isolated cleft 
palate.2 In 20 to 34% of the cases it is part of a syndrome, and 
associated with other congenital defects.3 About 45% of all patients 
with CLP have a cleft of the soft palate.4 
The levator veli palatini is the major muscle of the soft palate, 
which moves it up and down. This muscle is therefore critical for the 
functioning of the soft palate during speech, swallowing, and 
sucking. Children with a cleft palate can not separate the nasal from 
the oral cavity during speech, a phenomenon known as 
velopharyngeal dysfunction.5,6 The surgical repair of the soft palate 
normally takes place early in childhood at 6–36 months of age, 
although the protocols are highly variable.2 Surgery is required to 
close the defect and to reconstruct the palatal muscles.7 The aim is 
to restore the function of the soft palate allowing normal speech 
development.8,9 However, velopharyngeal dysfunction persists in 7 
to 30% of the patients, despite anatomical repositioning of the 
muscles during surgery.5,6,10–12 This results in speech 
abnormalities.13 Various factors such as age at the time of the 
surgery, skills and experience of the surgeon, type and extension of 
the cleft, and damage of the motor and proprioceptive nerves have 
been attributed to suboptimal repair.5,14–16 
In general, muscle tissue possesses a large ability to regenerate. 
Satellite cells (SCs) are the primary muscle stem cells, and 
responsible for postnatal muscle growth, maintenance, and repair.17 
Upon injury, SCs are activated and migrate to the wound, 
proliferate, differentiate, and form new myofibers or repair 
damaged ones.18 SCs are located between the basal lamina and the 
plasma membrane,17,19 and express the transcription factor 
Pax7.20,21 A distinct gene expression profile characterizes the SC 
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progeny.22,23 The myogenic determination factor 1 (MyoD) is 
expressed during SC proliferation, whereas differentiation is marked 
by a decline in Pax7 expression, and the induction of myogenin 
(MyoG).24 Differentiating myoblasts express various genes that 
encode structural proteins such as myosin heavy chain (MyHC), and 
finally fuse to form myotubes.25,26 SC differentiation and, hence, 
muscle repair is regulated by signaling molecules from infiltrating 
macrophages, injured myofibers, and the disrupted extracellular 
matrix.18,27 
Several strategies have been used in regenerative medicine to 
improve muscle regeneration. Growth factors, satellite cells, 
biological and synthetic scaffolds, or a combination of these have 
been applied to injured muscles with varying results.28–32 Most 
studies on muscle regeneration, however, have been performed in 
limb, trunk muscles, while studies on head muscles are scarce. 
Skeletal muscles from the trunk and limbs are derived from the 
somites during embryonic development,33 while most head muscles, 
including those of the soft palate, are derived from the branchial 
arches.34–36 Interestingly, head muscles generally contain less SCs 
than limb muscles.37 Head muscles also regenerate much slower 
than limb muscles after freeze, crush or similar injuries, and more 
fibrous connective tissue is generally formed during healing.38 
Proliferating SCs from head muscles also express a different profile 
of transcription factors.37 In addition, the muscles in the soft palate 
of CLP patients are smaller than normal palatal muscles and the 
myofibers are not properly organized.39,40 All this may contribute to 
the poor regeneration of soft palate muscles after surgical closure 
of the soft palate.41 Taken together, scar formation and incomplete 
muscle regeneration seem to be the main causes of muscle 
dysfunction after cleft palate repair, next to the already mentioned 
factors. 
Up to now, no animal models are available to investigate muscle 
regeneration in the soft palate. Therefore, the aim of this study was 
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to describe the anatomy and histology of the soft palate in rats, and 
to establish an in vivo model for muscle regeneration in the soft 
palate after surgical injury. 
 
 
Material and Methods 
 
Animals 
Ethics statement. Approval of the research protocol was obtained 
from the local Board for Animal Experiments (Dier Experimenten 
Commissie) from the Radboud University Nijmegen in accordance 
with Dutch laws and regulations (RU-DEC 2011-125). 
Fourteen adult male Sprague Dawley rats, weighing 280–300 g 
(Harlan BV, Horst, The Netherlands) were housed under standard 
laboratory conditions. The rats had been acclimatized to the animal 
facility for one week, before the start of the experiments. The 
animals were divided into four groups, group 1 (n=4) and group 2 
(n=2) to investigate the anatomy and histology of the soft palate, 
respectively. Group 3 (n=6) was used for surgical wounding of the 
soft palate, and group 4 (n=2) was used as unwounded control 
group. 
 
Experimental Procedures 
Dissection techniques 
Anatomical dissection of the soft palate was performed in four 
animals (Group 1) using an operating microscope (Carl Zeiss AG, 
Oberkochen, Germany) after euthanasia with CO2/O2. In the first 
stage, as described elsewhere,42 a ventral incision was made 
extending from the mandibular symphysis to the clavicle. The 
subcutaneous tissues were separated until the submandibular gland 
was visible. By removal of the salivary gland, the digastric and 
sternocleidomastoid muscles were then exposed. The posterior 
belly of the digastric muscle was dissected to its origin, and pulled 
laterally to expose the tympanic bulla. This procedure was 
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conducted at both sides, and the levator veli palatini was carefully 
dissected from its origin to its insertion in the soft palate. In the 
second stage, the mandibular ramus was cut on both sides, and the 
soft palate was dissected to examine the origin and course of the 
tensor veli palatini muscle. 
In group 2, the animals were decapitated after sacrifice with the 
standard CO2/O2 protocol, and the heads were fixed in 4% 
paraformaldehyde (PFA) for 24 hours at 4ºC, and then rinsed in 0.1 
M phosphate-buffered saline (PBS, pH 7.4). Serial coronal sections 
of 5 μm were cut for histochemical staining after decalcification in 
10% ethylenediaminetetraacetic acid (EDTA) and paraffin 
embedding. 
 
Excisional wounding of the soft palate 
Six animals (group 3) received buprenorphine (0.02 mg/kg s.c.; 
Temgesic, Schering Plough, Brussels, Belgium) as analgesic before 
surgery, and also at the next two days with twelve hour intervals. 
General anesthesia was induced with a mixture of ketamine (75 
mg/kg i.p.; Nimatek, Eurovet Animal Health B.V, Bladel, The 
Netherlands) and medetomidine (0.5 mg/kg i.p.; Dexdomitor, 
Janssen–Cilag B.V, Tilburg, The Netherlands). In addition, atropine 
(0.05 mg/kg i.m.; Atropine, Pharmachemie B.V, Haarlem, The 
Netherlands) was injected to prevent medetomidine-induced 
bradycardia. The animals were placed in a supine position on an 
operating table tilted at 45º to allow optimal surgical exposure of 
the soft palate. Body temperature was kept at 38ºC using a heating 
pad.  
All procedures were performed in semi-sterile conditions under 
an operating microscope (Carl Zeiss AG, Oberkochen, Germany) by 
the same operator (P.L.C.M) trained in microsurgical techniques. 
Chlorhexidine digluconate gel 0.2% (Orosol; Fresenius Kabi B.V, 
Schelle, Belgium) was used to clean the surgical area. Excisional 
wounds (1 mm ø) were made in the soft palate using a biopsy punch, 
seven mm behind the ninth palatal ruga (Figure 1). Reversion of the 
anesthesia was induced with atipamezol hydrochloride (0.5 mg/kg 
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i.p.; Antisedan; Janssen-Cilag B.V, Tilburg, The Netherlands). The 
animals received powdered chow in water during the following three 
days. Their behavior was monitored daily with special attention for 
water and food intake, loss of weight, and activity. The animals were 
euthanized with the standard CO2/O2 protocol after seven days. 
 
Histology 
After euthanasia, the soft palates of the six experimental animals 
(group 3) and two control animals (group 4) were dissected, fixed in 
4% PFA in PBS, and processed for paraffin embedding. Paraffin 
sections of the two heads (group 2) and the eight soft palates (group 
3 and 4) were stained with azocarmine G and aniline blue (AZAN) to 
discriminate collagen (blue) from muscle tissue (red). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Excisional wounding of the soft palate. Excisional wounds (1 mm ø) were 
made in the soft palate, 7 mm behind the 9th palatal ruga. W: excisional wound, R: 
9th ruga.  
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Immunohistochemistry 
Sections were deparaffinated, rehydrated, treated with 3% H2O2 for 
20 minutes to inactivate endogenous peroxidase, and post-fixed 
with 4% PFA in PBS. For Pax7 and MyoD staining, the sections were 
first heated in 0.25 mM EDTA/10 mM TRIS buffer (pH 9.0) at 100ºC 
for 10 minutes. For MyoG staining, the sections were first heated in 
citrate buffer (pH 6.0) for 40 minutes at 100ºC. For alpha-smooth 
muscle actin (ASMA) and fast myosin skeletal heavy chain (MyHC) 
staining, the sections were heated in citrate buffer (pH 6.0) at 70ºC 
for 10 minutes, and subsequently treated with 0.075% trypsin in PBS 
(pH 7.4) for 15 minutes to retrieve antigens. Sections were then 
incubated with mouse anti-ASMA (1:10.000; Chemical CO, St Louis, 
MO, USA), mouse anti-fast MyHC (1:5000; Sigma Chemical CO, St 
Louis, MO, USA), mouse anti-Pax7 (1:100; Developmental Studies 
Hybridoma Bank, Iowa City, CA USA), mouse anti-MyoD (1:50; 
DAKO, Dakopatts, Glostrup, Denmark), or mouse anti-myogenin 
(1:100; Developmental Studies Hybridoma Bank), overnight at 4ºC. 
Next, the sections were incubated with biotinylated secondary 
antibodies donkey-anti-mouse IgG (H+L) (1:500; Jackson Labs, West 
Grove, Pa, USA), and a preformed biotinylated horseradish 
peroxidase - avidin complex (Vector Laboratories, Burligame, CA, 
USA). The sections were stained with 3,3-diaminobenzidine 
substrate, and analyzed qualitatively. 
 
 
Results 
 
Anatomy of the Soft Palate Muscles 
In adult rats, the length of the soft palate is about 11 mm, which is 
relatively longer than in humans. It extends from the posterior edge 
of the hard palate (9th ruga) towards the nasopharyngeal sphincter 
(Figure 2). 
Figure 3 shows a schematic drawing of the levator veli palatini and 
tensor veli palatini muscles. Clinical pictures are presented in figures 
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4 A to D. The levator veli palatine muscle originates from the inferior 
surface of the temporal bone, and runs in medial and anterior 
direction (Figure 4A). It then runs posterior to the pterygoid process 
towards the soft palate, crosses the midline, and joins the 
contralateral levator veli palatini muscle fibers forming a muscle 
sling (Figure 4B). The glossopharyngeal, vagus and hypoglossal 
nerves are visible between the levator veli palatini and the skull base 
(Figure 4A and 4B). The tensor veli palatini originates from the 
inferior surface of the sphenoid bone, the lateral surface of the 
pterygoid plate, and the auditory tube (Figure 4C). It runs towards 
the pterygoid process and its tendon curves around the pterygoid 
hamulus. It then continues medially towards the soft palate and 
forms the palatine aponeurosis (Figure 4D) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. General aspect of the soft palate in rats. Left: Schematic representation 
of the soft palate (intraoral view). Right: The soft palate in the rat extends from the 
posterior edge of the hard palate (9th ruga) towards the nasopharyngeal sphincter. 
In adult rats, the length of the soft palate is about 11 mm. Ns: nasopharygeal 
sphincter, R: 9th ruga, M: molar. The red circle indicates the location of the 
excisional wound (1 mm ø). The dotted lines indicate the location of the histological 
sections shown in Figure 5. S: midsagittal section. B1, B2, and B 3 coronal sections.  
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Figure 3. Schematic representation of the levator veli palatini and tensor veli 
palatini muscles. LVP: levator veli palatini muscle, TVP: tensor veli palatini muscle, 
IX: glossopharyngeus nerve, X: vagus nerve, XII: hypoglossus nerve, Ty: Tympanic 
bulla, At: auditory tube, Et: eustachian tube, H: pterygoid hamulus, Pt: pterygoid 
process, PNS: posterior nasal spine.  
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Figure 4. Anatomy of levator veli palatini and tensor veli palatini. (A) The levator veli 
palatini muscle arises from the inferior surface of the temporal bone, lateral and 
posterior from the tympanic bulla. The tympanic bulla is a bony projection of the 
temporal bone containing the tympanic cavity. (B) Posterior to the pterygoid 
process, the levator veli palatini continues towards the soft palate. The 
glossopharyngeal, vagus and hypoglossal nerves are visible between the levator 
veli palatini and the skull base. (C) The tensor veli palatini originates from the 
inferior surface of the sphenoid bone, the lateral surface of the perygoid plate, and 
the auditory tube. (D) The tendon of the tensor veli palatini turns around a curved 
process; the pterygoid hamulus. It continues medially towards the soft palate and 
forms the palatine aponeurosis. LVP: levator veli palatini muscle, TVP: tensor veli 
palatini muscle, IX: glossopharyngeus nerve, X: vagus nerve, XII: hypoglossus nerve, 
Ty: Tympanic bulla, Et: eustachian tube, H: pterygoid hamulus, Pt: pterygoid 
process, PNS: posterior nasal spine, S: soft palate.  
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Histology of the Soft Palate 
Two main areas were identified in the soft palate, an anterior and a 
posterior area (Figure 5A). The anterior area is characterized by a 
thick layer of salivary glands, which is covered by a layer of oral 
(bottom) and nasal mucosa (top) (Figure 5B-2). 
 
 
 
A 
 
 
 
 
 
 
B 
 
 
 
 
 
 
Figure 5. Histology of the soft palate. Paraffin sections were cut from the tissue and 
stained with AZAN. (A) Midsagittal section of the soft palate. The anterior two thirds 
of the soft palate mainly contain salivary glands. The posterior third of the soft 
palate contains an additional layer of muscle tissue. (B) Coronal sections of the soft 
palate. The dotted lines in figure A indicate the position of the coronal sections. 
(B1) The palatine aponeurosis is the continuation of the tensor veli palatini and 
inserts into the posterior nasal spine. (B2) Posterior to the pterygoid hamulus, the 
levator veli platini fibers insert into the palatine aponeurosis. (B3) Most of muscle 
fibers of the levator veli palatini cross the midline and form a sling suspended from 
the skull base. N: nasal cavity, O: oral cavity, PA: palatine aponeurosis, SG: salivary 
glands, PNS: posterior nasal spine, LVP: levator veli palatini muscle, H: pterygoid 
hamulus. The bar represents 500 μm.  
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The oral surface is covered by a keratinized stratified squamous 
epithelium, while the nasal surface is covered by a pseudostratified 
ciliated columnar epithelium. The oral mucosa contains a thick 
collagenous submucosa. A thinner dense layer of collagenous tissue 
is present under the nasal epithelium; the palatine aponeurosis 
(Figure 5A). This is the continuation of the tensor veli palatini 
muscle, and inserts into the bony posterior nasal spine (Figure 5B-
1). In the posterior area of the soft palate, the nasal epithelium 
changes into a stratified squamous epithelium (Figure 5A). In 
addition, a layer of muscle tissue is present.  
Posterior to the bony pterygoid hamulus, the levator veli palatini 
muscle fibers insert into the palatine aponeurosis (Figure 5B-2). 
However, most of the levator veli palatini fibers cross the midline 
forming a muscle sling suspended from the skull base (Figure 5B-3). 
The nasopharyngeal sphincter is formed by the most posterior 
muscle fibers in the soft palate. The sphincter mainly contains fibers 
from the palatoglossal and palatopharyngeal muscles. The thick 
glandular layer gradually becomes thinner towards the posterior 
part of the soft palate (Figure 5A). 
 
Wound Healing in the Soft Palate 
Full-thickness defects (1 mm ø) were made in the soft palate of six 
rats (group 3), and left to heal for seven days. In addition, the soft 
palate of two other animals (group 4) was used as controls. All 
animals survived surgery, and showed no weight loss. After seven 
days, all wounds showed clinical healing. In the controls, both a layer 
of muscle tissue, and a layer of salivary glands are present (Figure 
6A left). The wounded palates show loss of the major parts of these 
layers (Figure 6A right). Collagenous granulation tissue is present in 
the wound area, and only limited regeneration of salivary glands and 
muscles has occurred (Figure 6A). 
ASMA is a marker for myofibroblasts. Myofibroblasts were not 
present in the controls tissue of the controls, except in blood vessels 
and salivary glands (Figure 6B). In contrast, large numbers of 
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myofibroblasts were present in the wound area at 7 days in the 
experimental group. In both groups, almost all myofibers were of 
the fast-twitch type (Figure 6C). More activated SCs (Pax7-, MyoD-, 
and MyoG-positive) were present in regenerating muscle fibers in 
the wound edges than in control muscle (Figure 7A, B, and C). 
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Figure 6. Regeneration of the soft palate after wounding. Control and wound 
tissues from the soft palate were stained with AZAN, and with antibodies against 
myofibroblasts (ASMA) and fast muscle fibers (Fast MyHC). After 7 days, extensive 
granulation tissue with collagen and myofibroblasts had formed. (A) AZAN 
staining. Connective tissue is stained blue, muscle tissue red. Black arrows 
indicate muscle fibers, white arrows indicate initial regeneration of salivary 
glands. SG: Salivary glands. (B) ASMA (Brown). Myofibroblasts were not present 
in the controls, except in blood vessels and salivary glands. In contrast, large 
numbers of myofibroblasts were present in the wound area at 7 days in the 
experimental group. (C) Fast MyHC (brown). In both groups, almost all myofibers 
were of the fast-twitch type. Wound margins are indicated by the dotted lines. 
The bar represents 200 μm. 
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Figure 7. Satellite cells and myofibers after wounding. Control and wound tissues 
were stained with antibodies against Pax7, MyoD, and MyoG. Large numbers of 
activated satellite cells and regenerating myofibers are present in the 
experimental group. (A) Satellite cells (arrows) express the transcription factor 
Pax7. (B) The myogenic determination factor 1 (MyoD, arrows) is expressed 
during satellite cell proliferation. (C) Differentiation is marked by a decline in Pax7 
expression, and the induction of myogenin (MyoG, arrows). Pax7-, MyoD-, and 
MyoG positive cells are stained brown. The bar represents 50 μm.  
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Discussion 
 
Speech abnormalities are commonly observed in children with a 
history of a cleft in the soft palate. This can have a devastating effect 
on their interaction with other children and adults.15 The 
regeneration of muscles in the soft palate after surgery may be 
hampered because of (1) their low intrinsic regenerative capacity, (2) 
the specific muscle properties related to clefting, and (3) the 
development of fibrosis.41 The outcome of surgery may be improved 
by novel strategies based on tissue engineering. 
A suitable animal model is required to design and optimize new 
strategies for soft palate repair. To our knowledge, we present the 
first model for the regeneration of the soft palate following surgical 
wounding. Our study shows that the anatomy and histology of the 
soft palate muscles of the rat are largely comparable to those of 
humans. The levator veli palatini and tensor veli palatini muscles in 
the rat were shown to have a similar origin and course as its 
homologous in humans.43–45 In contrast, the muscular component of 
the soft palate in rats occupies only the posterior third of the 
tissue,44 while in humans this is about half. The levator veli palatini 
is the most important muscle for the elevation of the soft palate in 
both humans and rodents.40,42,44 Together, the tensor veli palatini 
and the levator veli palatini also control the passage of air through 
the auditory tube.46,47 The widespread use of rodents in biomedical 
research ensures the availability of antibodies for specific immune 
staining. In combination with the ease of handling and low costs. 
this makes the rat the most suitable animal model. 
Our model consists of a full-thickness defect in the soft palate that 
creates a temporal communication between the nasopharynx and 
the oropharynx, and thus increases the risk of bronchoaspiration. 
Therefore, the animals were closely monitored during the seven 
days after surgery. No complications were observed during this 
period. 
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Extensive collagen deposition and initial regeneration of muscle 
fibers and salivary glands was demonstrated after 7 days. Collagen 
is deposited by fibroblasts in the granulation tissue. It has been 
previously shown that fibroblasts proliferate in close association 
with satellite cells and regenerating myofibers.48 Fibroblasts then 
stimulate the proliferation of satellite cells during the early phase of 
regeneration. Later in the regeneration process, the number of 
fibroblasts normally decreases to allow the formation of new muscle 
fibers. Growth factors such as transforming growth factor-1 (TGF-
1) induce the differentiation of fibroblasts into myofibroblasts, 
which produce large amounts of extracellular matrix.49,50 In addition, 
myofibroblasts induce wound contraction. The prolonged presence 
of myofibroblasts in the wound leads to fibrosis.29,49 Since activated 
SCs do not migrate into fibrotic tissue, this may impair muscle 
regeneration and functional recovery of the muscle tissue after 
injury.51 
Both fast- and slow-twitch fibers have been found in human soft 
palate muscles.52,53 In contrast, we mainly found fast-twitch fibers in 
the rat soft palate. However, slow-twitch fibers were also found in 
the more lateral parts of the levator veli palatini muscle in rats.54 In 
our study, Pax7-, MyoD-, and MyoG-positive cells were found at the 
wound edges, demonstrating the presence of activated SCs and 
differentiating myofibers. In limb muscles, activated SCs and 
regenerating myofibers also appear after about one week.48,51,55,56 
In limb muscles, SCs proliferate extensively within the first 2–3 days 
after injury.57 At about 5 days after injury, activated SCs differentiate 
into myoblasts and fuse, which leads to restoration of the injured 
muscle within 10 days.57 In contrast, injured head muscles do not 
restore within 12 days.38 This indicates that the regeneration of head 
muscles is slower than that of limb muscles. Thus, further studies are 
necessary in order to fully characterize the regeneration of soft 
palate muscles. 
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Conclusion 
 
The presented rat model is suitable to study muscle regeneration in 
the soft palate after surgical injury, and allows the development of 
novel adjuvant strategies to promote muscle regeneration. This 
offers new perspectives for the treatment of CLP patients, and for 
various other conditions in which the regeneration of head muscles 
is compromised. 
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Abstract 
Muscle repair is a crucial component of palatoplasty but little is 
known about muscle regeneration after cleft palate repair. We 
hypothesized that the formation of new myofibers is hampered by 
collagen accumulation after experimental injury of the soft palate 
of rats. One millimeter excisional defects were made in the soft 
palates of 32 rats. The wound area was evaluated after 3, 7, 28, 
and 56 days using azocarmine G and aniline blue to stain for 
collagen and immunohistochemistry to identify myofibroblasts 
and to monitor skeletal muscle differentiation. To evaluate age 
effects, 16 unwounded animals were evaluated at 3 and 56 days. 
Staining was quantified by image analysis, and one-way ANOVA 
was used for the statistical analysis. At day 56, the area 
percentage of collagen-rich tissue was higher in the injured 
palatal muscles (46.7±6.9%) than in non-wounded controls 
(15.9±1.0%, p<0.05). Myofibroblasts were present in the injured 
muscles at days 3 and 7 only. The numbers of proliferating and 
differentiating myoblasts within the wound area were greater at 
day 7 (p<0.05), but only a few new myofibers had formed by 56 
days. No age effects were found. The results indicate that surgical 
wounding of the soft palate results in muscle fibrosis. Although 
activated satellite cells migrated into the wound area, no new 
myofibers formed. Thus, regeneration and function of the soft 
palate muscles after injury may be improved by regenerative 
medicine approaches. 
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Velopharyngeal dysfunction is common after surgical repair of the 
soft palate.1 Several causative factors have been proposed, 
including age at surgery, the skills and experience of the surgeon, 
cleft type and extension, repair technique, and fibrosis.2-5 Muscle 
fibrosis seems to be a major factor. Although muscle repair is an 
important component of contemporary palatoplasty,4 little is known 
about muscle regeneration after cleft palate repair. 
The ability of skeletal muscle to regenerate through the action of 
satellite cells (SCs) is well established.6 Upon injury, SCs become 
activated and migrate to the site of injury, where they proliferate, 
differentiate into myoblasts, and fuse to form new myofibers or 
repair damaged ones.7 Quiescent SCs express the transcription 
factor Pax7;8 proliferating myoblasts also express the myogenic 
determination factor 1 (MyoD).9 Differentiating myoblasts start to 
express myogenin (MyoG)10 and terminal differentiation is marked 
by the expression of muscle-specific proteins, such as fast myosin 
heavy chain (MyHC).11 
Several experimental strategies have been used in regenerative 
medicine to improve muscle regeneration.12 Most of these studies 
have been performed on limb or trunk muscles, and studies on 
branchiomeric muscles are scarce. Branchiomeric muscles originate 
from the branchial arches and include the masseter and levator veli 
palatini muscles. Branchiomeric muscles have been suggested to 
contain fewer SCs and regenerate slower than limb muscles.13 
Compared to limb muscles, more fibrous connective tissue seems 
to form when branchiomeric muscles heal.14 Proliferating SCs from 
branchiomeric muscles have a different transcription factor profile 
than limb muscle.13 Moreover, muscles in the soft palate of cleft 
patients are usually smaller and less well-organized than palatal 
muscles from healthy subjects.15,16 All of these factors may 
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contribute to the poor regeneration of the soft palate muscles after 
surgical cleft closure.17 
Therefore, it is crucial to characterize the regeneration of the soft 
palate muscles after injury and to develop specific strategies for 
improving muscle regeneration. In this study, we investigate 
regeneration of the soft palate muscles and the formation of fibrotic 
tissue after excisional palatal injury in a rat model. 
 
 
Material and Methods 
 
Animals 
The protocol was approved by the local Board for Animal 
Experiments at Radboud University Nijmegen in accordance with 
Dutch laws and regulations (RU-DEC-2011-125). Forty-eight adult 
male Sprague Dawley rats weighing 280–300 g (Harlan BV, Horst, 
the Netherlands) were housed under standard laboratory 
conditions. The rats had been acclimatized to the animal facility for 
one week before the start of the experiments. The animals were 
randomized into six groups (n=8, Table 1). Groups 1 and 6 were 
used as unwounded age controls, whereas groups 2-5 were used 
for surgical wounding (Table 1). 
 
 
Table 1. Groups and time points 
Group Type Time point n 
1 Age control 3 days 8 
2 Experimental 3 days 8 
3 Experimental 7 days 8 
4 Experimental 28 days 8 
5 Experimental 56 days 8 
6 Age control 56 days 8 
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Excisional wounding of the soft palate 
As previously described,18 the animals received buprenorphine 
(0.02 mg/kg s.c.; Temgesic, Schering Plough, Brussels, Belgium) as 
an analgesic before surgery and at 12-h intervals for the next 2 days. 
Briefly, animals in groups 2-5 were anesthetized and placed on an 
operating table in a supine position for surgery. An excisional 
wound (1 mm ø) was made 7 mm behind the ninth palatal ruga using 
a biopsy punch. After reversion of the anesthesia and over the 
following 3 days the animals received powdered chow in water. 
Their behavior was monitored daily with special attention to water 
and food intake, weight loss, and activity. Animals were euthanized 
using the standard CO2/O2 protocol after 3, 7, 28, and 56 days. 
 
Histology  
The soft palate of each animal was dissected, fixed in 4% 
paraformaldehyde (PFA) in PBS, and processed for paraffin 
embedding. Paraffin sections were stained with azocarmine G and 
aniline blue (AZAN) to identify connective tissue/collagen (blue) and 
muscle tissue (red). 
 
Immunohistochemistry 
Sections were stained as described previously.18 The following 
primary antibodies were used: mouse anti-Pax7 (1:100; 
Developmental Studies Hybridoma Bank, Iowa City, IA, USA), 
mouse anti-MyoD (1:50; DAKO, Dakopatts, Glostrup, Denmark), 
mouse anti-myogenin (1:100; DSHB), mouse anti-alpha-smooth 
muscle actin (-SMA, 1: 10,000; Chemical Co., St Louis, MO, USA), 
and mouse anti-fast MyHC (1:5000; Sigma Chemical Co.). 
 
Quantification 
All AZAN- and antibody-stained sections were visualized using a 
Zeiss microscope (Carl Zeiss Microimaging GmbH, Jena, Germany) 
and photographed. The muscle layer was digitally isolated from 
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each photograph using Adobe Photoshop (CS5 Extended 12.0x32; 
Adobe Systems, San Jose, CA). Subsequently, two areas of interest 
were demarcated, a central area corresponding to the wound area 
(700 μm) and two lateral areas on both sides of the wound (500 μm 
per side, Figure 1). For AZAN, -SMA, and MyHC staining, the 
percentage of stained area was determined using a macro in Fiji.19 
The number of Pax7-, MyoD-, and MyoG-positive cells was counted 
in both the central and lateral areas and expressed as cells/mm2. All 
data are expressed as the mean percentage ± SD of the total area. 
 
Data analysis and statistics 
All data were analyzed by one-way ANOVA and a Kruskal-Wallis 
post-hoc test. p<0.05 was considered significant. Differences 
between the experimental and age control groups were analyzed at 
days 3 and 56. Differences between all experimental groups were 
analyzed on days 3, 7, 28, and 56. Differences between the two age 
control groups at were analyzed at days 3 and 56. 
 
 
Results 
 
Clinical and histological observations following palatal injury 
Pilot studies in rats revealed that incisional wounding of the soft 
palate results in full muscle regeneration, whereas excisional 
wounding (full-thickness defects of 1 mm Ø) impairs healing. We 
chose the latter wound model because the outcome of excisional 
wounding is more comparable to clinical cleft palate repair. 
One animal (group 2) died during the surgical procedure due to 
oronasal obstruction. On day 7, all wounds demonstrated clinical 
healing. However, after histological analysis we found that six 
wounds had not closed completely, but had developed an oronasal 
communication lined with epithelium. These excisional wounds may 
have been made too close to the nasopharyngeal sphincter, and its 
FIBROSIS IMPAIRS FORMATION OF NEW MYOFIBERS 
 
89
contractile activity may have counteracted wound closure. These 
specimens from groups 4 (n=3) and 5 (n=3) were excluded from 
further analysis. Two main layers are present in the soft palate of 
the rat: an upper layer containing the muscles and a lower layer 
containing the salivary glands (Figure 1). The oral surface is covered 
by a keratinized stratified squamous epithelium, whereas the nasal 
surface is covered by a pseudostratified ciliated columnar 
epithelium. After digital isolation of the muscle layer, three areas of 
interest were chosen: one central area and two lateral areas. All 
measurements were performed in these areas (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Regions of interest. This figure shows both the dissected soft palate (left) 
and a frontal AZANstained section (right) for the control group on day 3. The 
dotted white line indicates the level of the histological section (left). Two main 
layers are present in the soft palate: an upper layer containing the muscles (area 
between black dotted lines) and a lower layer containing the salivary glands. All 
AZAN- and antibody-stained sections were photographed, and the muscle layer 
was isolated digitally. Next, two areas of interest were identified, a central area 
corresponding to the wound area (700 μm) and two lateral areas on both sides of 
the wound (500 μm per side). PNS: tip of posterior nasal spine, Ns: nasopharyngeal 
sphincter, L: lateral area, C: central area, NE: nasal epithelium, M: muscle, SG: 
salivary glands. and OE: oral epithelium.  
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Collagen quantification and myofibroblast staining 
To measure collagen deposition, sections were stained with AZAN 
(Figure 2). After full thickness wounding, the muscle and salivary 
gland layers were completely lost. By day 3 the wound was filled 
with a blood clot, which was replaced with granulation tissue by day 
7 (not shown). By day 56 the wound area was occupied by 
collagenous tissue (Figure 2, left and center). Over time, the amount 
of collagen (Figure 2, right) in the central area increased from 18 ± 
4.0% on day 7 to 46.7 ± 6.9% on day 56 (p<0.05). The amount of 
collagen in the central area was significantly greater in the 
experimental group (46.7 ± 6.9%) than in the age control (15.9 ± 
1.0%, p<0.05) at day 56. No significant differences were found 
between the age controls at days 3 and 56. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. AZAN staining and quantification. Control and wound sections from the 
soft palate were stained with AZAN to discriminate collagen from muscle tissue 
(area between white dotted lines). Sections from experimental (left) and control 
(center) animals on day 56. Quantification of the amount of collagen (right) is 
expressed as the mean percentage ± SD of the total area. #p<0.05 between the 
experimental groups, *p<0.05 between experimental and control groups at day 
56.   
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To identify myofibroblasts, paraffin sections were stained with 
antibodies against -SMA (Figure 3). In the age control groups, -
SMA-positive cells were only present in blood vessels and the 
myoepithelium of the salivary glands. In the experimental groups, 
myofibroblasts were present in the lamina propia of the nasal and 
oral mucosa already by day 3, but also in the muscular and glandular 
layers by day 7 (Figure 3, left). By days 28 and 56, only blood vessels 
and myoepithelial cells were present (Figure 3, center). At day 3, 
the -SMA-positive area (Figure 3, right) in the experimental group 
was significantly larger in both the central and lateral areas (lateral: 
14.4 ± 7.0%, center: 25.5 ± 9.4%, p<0.05) compared to the controls 
(lateral: 4.2 ± 1.3%, center: 5.5 ± 0.9%, p<0.05). Myofibroblasts 
were present in the central area on day 7 and significantly 
decreased from 32.0 ± 8.5% to 7.3 ± 1.5% by day 56 (p<0.05). No 
significant differences were found between the age controls at days 
3 and 56. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. -SMA immunostaining and quantification. Control and wound sections 
were stained with antibodies against -SMA to identify myofibroblasts (arrows). 
Sections from wounds on day 7 (left) and day 56 (center) are shown. The 
quantification of -SMA (right) is expressed as the mean percentage ± SD of the 
total area. #p<0.05 between the experimental groups, *p<0.05 between 
experimental and control groups at day 3.  
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Satellite cell activation 
Sections were stained with antibodies against Pax7 to identify SCs. 
SCs first appeared in the lateral area by day 3 and in the central 
area by day 7 (Figure 4, above, left). The number of SCs increased 
from day 3 to day 7 and then decreased up to day 56. The number 
of SCs is illustrated in Figure 4 (above, right). Only a few SCs were 
present in the controls. The number of SCs was 2-fold higher in the 
lateral area of the experimental group than in the age control group 
at day 3 (p<0.05). In addition, the number of SCs in the 
experimental group was significantly higher in both areas at day 7 
(central: 1.6-fold, lateral: 4.7-fold) compared to day 3 (p<0.05). No 
significant differences were found between the age controls at 3 
and 56 days. 
 
Satellite cell proliferation 
Sections were stained with antibodies against MyoD to identify 
proliferating SCs. Proliferating SCs first appeared in the lateral area 
by day 3 and in the central area by day 7 (Figure 4, center, left). The 
number of proliferating SCs increased from day 3 to day 7 and then 
decreased to day 56. The number of proliferating SCs is illustrated 
in Figure 4 (center, right). Only a small number of proliferating SCs 
were present in the controls. The number of proliferating SCs was 
10-fold higher (p<0.05) in the lateral area of the experimental group 
than in the age control group at day 3. In addition, on day 7 the 
number of proliferating SCs was 4.3- and 6.8-fold higher (p<0.05) 
in the central and lateral areas, respectively, compared to the 
experimental group on day 3. No significant differences were found 
between the age controls at 3 and 56 days. 
 
Satellite cell differentiation 
Sections were stained with antibodies against MyoG to evaluate the 
differentiation of SCs. As expected, differentiating SCs first 
appeared in the lateral area by day 3 and the central area by day 7 
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(Figure 4, below, left). The number of differentiating SCs increased 
from day 3 to day 7 and then decreased to day 56. The number of 
differentiating SCs is illustrated in Figure 4 (below, right). Only a 
few differentiating SCs were present in the controls. The number of 
differentiating SCs was 143-fold higher (p<0.05) in the lateral area 
of the experimental group compared to its age control group at day 
3. On day 7 the number of differentiating SCs was 1.4- and 3.1-fold 
higher (p<0.05) in the central and lateral areas, respectively, 
compared to the experimental group at day 3. No significant 
differences were found between the age controls at 3 and 56 days. 
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Figure 4. Pax7, MyoD, and MyoG immunostaining and quantification. Sections 
were stained with antibodies against Pax7 (above, left), MyoD (center, left), and 
MyoG (below, left) on day 7 to evaluate activated SCs, proliferating SCs, and 
differentiating myoblasts, respectively. The number of cells positive for Pax7 
(above, right), MyoD (center, right), and MyoG (below, right) was quantified and 
expressed as cells/mm2 ± SD of the total. #p<0.05 between the experimental 
groups, *p<0.05 between experimental and control groups at day 3. 
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Myofiber formation 
To identify myofibers, sections were stained with antibodies against 
fast MyHC (Figure 5). At 56 days, fewer myofibers were present in 
the central area of experimental animals compared to the controls 
(Figure 5, left and center). At day 3, the MyHC-positive area (Figure 
5, right) in the experimental group was significantly smaller in both 
the lateral and central areas (lateral: 47.1 ± 8.9%, central: 1.4 ± 
2.8%) compared to the age control (lateral: 66.8 ± 4.6%, central: 
67.1 ± 3.7%, p<0.05). In the experimental groups, the MyHC-
positive area in the center increased from 12.8 ± 6.8% on day 6 to 
28.2 ± 5.9% on day 56 (p<0.05). However, by day 56, the MyHC 
area was significantly smaller (28.2 ± 5.9%) in the experimental 
groups than in the age controls (56.5 ± 4.4%, p<0.05). No 
significant differences were found between the age controls at 3 
and 56 days. 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 5. MyHC staining and quantification. Sections were stained with antibodies 
against fast MyHC to identify myofibers. Sections from experimental (left), and 
control (center) animals at day 56 are shown. Quantification of the amount of MyHC 
(right, area between black dotted lines) is expressed as the mean percentage ± SD 
of the total area. #p<0.05 between the experimental groups, *p<0.05 between 
experimental and control groups at day 56. 
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Discussion 
 
The aim of this study was to evaluate the regeneration of myofibers 
and the development of fibrotic tissue after injury. We previously 
demonstrated that the anatomy and histology of the soft palate 
muscles of the rat are largely comparable to that of humans.18 Here, 
we show for the first time that muscle regeneration in the soft palate 
of the rat after excisional injury is incomplete. Extensive fibrotic 
tissue developed with little or no formation of new myofibers. 
Therefore, the original architecture of the muscle layer was not 
restored. First, the wounds filled with a blood clot, which was 
gradually replaced by granulation tissue that developed into 
fibrotic tissue. 
In our study, activated SCs and proliferating and differentiating 
SCs appeared early during wound healing, but myotube formation 
did not occur in the first week after injury. Similar results were found 
in a full-thickness wound model in the limb muscles of rats.20 
However, in that study no SCs were found within the wound area at 
any time point, which may be related to the muscle type or larger 
defect size (2 mm vs. 1 mm Ø). In other types of limb muscle injury 
without a tissue defect, such as freezing, crushing, or the 
application of myotoxic drugs, the muscle damage is not as 
extensive as in our model. In these models, the SCs proliferate 
extensively during the first few days and new myotubes appear 
within one week.21 Previous studies suggest that SC proliferation in 
branchiomeric muscles takes longer than in limb muscles, 
preventing adequate muscle regeneration.13,14 Therefore, care 
must be taken when comparing studies in different muscles. 
We also observed that only a few new myofibers had formed after 
56 days despite the early presence of differentiated SCs. In 
addition, collagen-rich tissue had developed in the wound area. 
Transforming growth factor-1 (TGF-1) and myostatin, both 
members of the TGF- super family of growth factors, can induce 
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fibrosis in skeletal muscle after injury. TGF-1 plays a significant role 
in the initiation of fibrosis and induces the differentiation of 
fibroblasts into myofibroblasts, which are mainly responsible for the 
excessive production of collagen and other components of the 
extracellular matrix.20,22 Myostatin stimulates fibroblast 
proliferation, reduces the migration of macrophages and 
myoblasts, and inhibits myoblast differentiation.23,24 Myostatin 
knockout mice have significantly less fibrosis in injured muscle.24,25 
Moreover, myostatin up-regulates the expression of TGF-1 in 
injured muscle, and vice versa.25 These factors may contribute to 
fibrosis in our model. In our study, myofibroblasts were present 
early after wounding, suggesting that they are not directly 
responsible for fibrosis. However, because the area of damaged 
tissue is large and revascularization may be compromised, the 
ischemic conditions may favor fibroblast proliferation and scar 
tissue formation.26 In our study and others, SCs seem to actively 
migrate into the injured area27,28; however little or no formation of 
new myofibers in the wound area were evident after 56 days. 
Regenerating muscle fibers generally develop along the basal 
lamina of the injured muscle.29,30 In a full-thickness defect like our 
model, the cell membrane and basal lamina of the muscle fibers are 
completely lost. Without the guidance of these structures, the 
regeneration of muscle fibers is probably impaired further.30-32 In 
addition, disturbed myoblast fusion could result from impaired cell-
extracellular matrix (ECM) signaling because of changes in the 
ECM.33,34 However, further studies are warranted to better 
understand how the ECM, the cell membrane and the basal lamina 
affect SC activity and fusion.29,35 Thus, ischemia, collagen 
accumulation, the loss of structural guidance, and changes in the 
ECM may hamper myoblast fusion and myofiber formation. 
In the clinic, the three major factors that limit muscle regeneration 
and promote fibrosis following cleft surgery seem to include: 1) 
inadequate reconstruction of the levator veli palatini muscle sling, 
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as adequate alignment of muscles fibers ensures proper guidance 
for the regenerating myofibers; 2) induced trauma, limited 
revascularization, and re-innervation of the cleft palate muscles, as 
the duration of surgery and extensive mobilization of the dissected 
muscles during soft palate repair compromise vascularization, which 
is essential for the early events in regeneration, such as the 
inflammatory response36; and 3) intrinsic muscle abnormalities 
associated with the cleft, such as atrophy and reduced capillary 
supply, which may contribute to suboptimal regeneration. 
Excessive lateral dissection of the levator veli palatini can damage 
the innervation of the soft palate muscles.37 Innervation is initially 
not required for regeneration, but when the new myofibers are not 
nerve-activated they will fail to mature and become atrophic. 
Eventually, these myofibers degenerate and are replaced by 
connective tissue.38,39 It is important to realize that fibrosis can 
increase in cases that require multiple surgical interventions.40  
In summary, we developed a new model for fibrosis-
compromised muscle regeneration in the soft palate by introducing 
a full-thickness defect. Muscle regeneration begins with the 
activation, recruitment, and proliferation of SCs from the wound 
margins early in wound healing. However, differentiated myoblasts 
within the wound fail to form new myofibers as large amounts of 
collagen are deposited in the wounded area. Two possible issues 
need to be further investigated: the loss of structural guidance by 
muscle membranes and the effect of fibrosis on the formation of 
myofibers. Proper alignment of regenerating myotubes may be 
achieved with scaffolds of specific design and surface topography, 
whereas the use of growth factors and/or ECM components may 
limit the development of fibrosis. This model provides a tool for 
developing novel strategies based on tissue engineering to 
improve the outcomes of cleft palate surgery. The use of isolated 
SCs, growth factors, and suitable scaffolds may improve muscle 
regeneration and function after cleft palate repair. 
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 Abstract 
Fibrosis and defective muscle regeneration can hamper the 
functional recovery of the soft palate muscles after cleft palate 
repair. This causes persistent problems in speech, swallowing, and 
sucking. In vitro culture systems that allow the study of satellite 
cells (myogenic stem cells) from head muscles are crucial to 
develop new therapies based on tissue engineering to promote 
muscle regeneration after surgery. These systems will offer new 
perspectives for the treatment of cleft palate patients. A protocol 
for the isolation, culture and differentiation of satellite cells from 
head muscles is presented. The isolation is based on enzymatic 
digestion and trituration to release the satellite cells. In addition, 
this protocol comprises an innovative method using extracellular 
matrix gel coatings of millimeter size, which requires only low 
numbers of satellite cells for differentiation assays. 
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About 1:500 to 1:1,000 newborns exhibit a cleft involving the lip 
and/or palate (CLP); thus this is the most common congenital 
malformation in humans.1 The muscles of the soft palate are 
critical for the functioning of the soft palate during speech, 
swallowing, and sucking. If a cleft of the soft palate is present, 
these muscles are abnormally inserted into the posterior end of 
the palatal bone. 
The soft palate moves backwards to the posterior pharyngeal 
wall (by retraction of the levator veli palatini muscle) during 
speech, preventing air to escape through the nose. Children with 
a cleft in the palate do not have this control function resulting in a 
phenomenon known as velopharyngeal dysfunction.2,3 Although 
the treatment protocols are variable, surgical repair of the soft 
palate takes place in early childhood (6-36 months of age).4 The 
abnormally inserted muscles of the soft palate can be surgically 
corrected,5-7 however, velopharyngeal dysfunction persists in 7% 
to 30% of the patients.2,3,8-10 
The ability of skeletal muscle to regenerate through the action 
of satellite cells (SCs) is well established.11,12 Upon muscle injury, 
SCs are activated and migrate to the site of injury. They then 
proliferate, differentiate, and fuse to form new myofibers or repair 
damaged ones13. Quiescent SCs express the transcription factor 
Pax7,14,15 while their progeny, the proliferating myoblasts, 
additionally express the myogenic determination factor 1 
(MyoD).16 Differentiating myoblasts start to express myogenin 
(MyoG).17 The terminal differentiation of myoblasts is marked by 
the formation of myofibers, and the expression of muscle-specific 
proteins such as myosin heavy chain (MyHC).16,18 
Recently, several strategies have been used in regenerative 
medicine to improve muscle regeneration of limb muscles.19-23 
Specific studies on branchiomeric head muscles are also important 
because it was recently demonstrated that they differ from other 
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muscles in several aspects.24 In contrast with limb muscles, it has 
been suggested that branchiomeric head muscles contain less 
SCs,25 regenerate slower, and more fibrous connective tissue is 
formed after injury.26 In addition, proliferating SCs from 
branchiomeric head muscles also express other transcription 
factors. For instance, Tcf21, a transcription factor for craniofacial 
muscle formation is strongly expressed in regenerating head 
muscles but hardly in regenerating limb muscles.25 The muscles in 
the soft palate of CLP patients are usually smaller and less well-
organized compared to normal palatal muscles.27,28 Slow and fast 
fibers are both present in the soft palate muscles but the slow 
fibers are more abundant. In contrast, cleft muscles contain a 
higher proportion of fast fibers and also a reduced capillary supply 
compared with normal soft palate muscles.29-31 Fast fibers are 
more prone to contraction-induced injury.31-33 The accompanying 
poor capillary supply may also promote fibrosis.34,35 All these 
aspects may contribute to the poor regeneration of soft palate 
muscles after surgical cleft closure.36 In view of this, a protocol for 
the isolation and characterization of branchiomeric head muscle 
SCs is crucial. This provides the possibility to study SC biology of 
branchiomeric head muscles. 
In addition, new therapies based on tissue engineering can be 
developed to promote muscle regeneration after surgery in CLP 
and other conditions compromising the craniofacial area. 
In general, SCs can be obtained after dissociation of muscle 
tissue.14 Mincing, enzymatic digestion, and trituration are 
generally required to release SCs from their niche. SCs can be 
purified by pre-plating on uncoated dishes,14,37,38 fractionation on 
Percoll,39,40 or fluorescent- or magnetic cell sorting.41-43 Here we 
present a new economic and rapid protocol for the isolation of 
satellite cells from branchiomeric head muscles of young adult 
rats. This protocol is based on a previous manuscript14 and 
specifically adapted for small tissue samples. The isolation of SCs 
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from representative muscles originating from the 1st, 2nd, and 4th 
branchial arches are described. After isolation, low numbers of 
satellite cells are cultured on extracellular matrix gel spots of 
millimeter size to study their differentiation. This approach avoids 
the requirement for the expansion and passaging of SCs. 
 
 
Protocol 
 
All experiments described herein were approved by the local 
Board for Animal Experiments from the Radboud University 
Nijmegen in accordance with Dutch laws and regulations (RU-DEC 
2013-205). 
 
Extracellular Matrix Gel Spots 
Perform the following steps one day before the isolation: 
1. Thaw an aliquot extracellular matrix gel (100 μl) at 4°C for at 
least 1.5 hr. Dilute 1:10 in Dulbecco's modified Eagle's 
medium; with 4,500 mg/L glucose, 4 mM L-glutamine, and 110 
mg/ml sodium pyruvate (DMEM). Keep the extracellular matrix 
gel at 4°C at all times. 
 
Note: Abrupt temperature changes will result in uneven   coating 
and crystal formation. 
 
2. Keep the diluted extracellular matrix gel solution on ice for 15 
min. 
3.  Pre-chill a 20 μl micropipette for 10 min. 
4.  Put 8-well chamber slides into a 100 mm Petri dish and transfer 
the dish onto a cold surface (e.g. a freezer pack) for 10 min. 
5.  Use the pre-chilled micropipette to put a drop of 10 μl 
extracellular matrix gel in each well. Keep the Petri dish on the 
cold surface for at least another 7 min (Figure 1A). 
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6.  Completely remove the remaining extracellular matrix gel 
(Figure 1B), and dry the wells at 37°C overnight. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Extracellular matrix gel spots in a chamber slide. (A) For easy 
manipulation, place the 8-well chamber slide into a 100 mm Petri dish. Pipet 10 
μl extracellular matrix gel in each chamber and put it on a cold surface (7 min). (B) 
Chamber slide after the excess extracellular matrix gel is removed. 
 
Dissection of Head Muscles (Masseter, Digastric, and Levator Veli 
Palatini) 
1. Before dissection, prepare 50 ml of phosphate-buffered saline 
(PBS) supplemented with 2% Penicillin-Streptomycin (P/S). 
Keep on ice.  
2. After euthanasia of one young adult rat (9 weeks) with 
CO2/O2, decapitate the head and remove the skin from the 
head. Transfer the head to ice-cold PBS supplemented with 2% 
P/S in a 50 ml tube. 
3. Masseter muscle (derived from the 1st branchial arch) 
 - Place the head with one side up on a silicone pad and fix with 
hypodermic needles (Figure 2A). 
 - Identify the parotid gland and the facial nerve (Figure 2A). 
Expose the deep fascia covering the gland. Cut the fascia and 
remove the gland using dissection scissors. Identify the 
external auditory canal. Trace the facial nerve from the 
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stylomastoid foramen and carefully  remove the temporal, 
zygomatic, and buccal branches with a scalpel blade No. 15. 
 - Free the superficial head of the masseter muscle by removing 
the fascia. Identify both superficial and deep heads of the 
masseter muscle. Trace the superficial head until its thick 
tendinous aponeurosis inserted in the zygomatic process of the 
maxilla. 
 - Separate the tendon from its origin at the zygomatic process 
with a straight forceps. Cut it with a scalpel blade No. 15 or 
dissection scissors and carefully life it (Figure 2B). 
 - Dissect the superficial head of the masseter until its insertion 
at the angle and inferior half of the lateral surface of the ramus 
of the mandible with a scalpel blade No. 15 (Figure 2C). Now, 
completely remove the muscle. 
 
 
 
 
 
     
    A         B 
 
 
 
 
 
     C 
Figure 2. Dissection of the masseter muscle. (A) Head of the animal in a lateral 
view. Ear (E), Parotid gland (P) and facial nerve (VII). (B) Tendinous aponeurosis 
(Te) of the superficial head of the masseter muscle (Ms) and temporal muscle (T). 
Separate the tendon from its insertion with a forceps. (C) Carefully dissect the 
muscle until its insertion at the ramus of the mandible. E: ear, P: parotid gland, 
VII: facial nerve, T: Temporal muscle, Ms: superficial head of the masseter 
muscle, Te: tendon, Mp: deep head of the masseter muscle. 
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4. Posterior belly of the digastric muscle (derived from the 2nd 
branchial arch) 
 - Place the head in a supine position on the silicone pad and fix 
with hypodermic needles (Figure 3A). 
 - Remove the subcutaneous fat overlying both sublingual and 
submandibular glands. Next, remove the superficial fascia and 
glands using dissection scissors. Expose the digastric muscle 
(anterior and posterior belly). 
 - Hold the anterior tendon of the posterior belly with a straight 
forceps, cut it, and dissect it carefully until its origin in the 
tympanic bulla (Figure 3B). Do the same at the contralateral 
side. 
 
 
 
 
 
 
 
 
 
 
 
 
   A           B 
 
Figure 3. Dissection of the posterior belly of the digastric muscle. (A) Head of the 
animal in a supine position. Localize the submandibular gland (Sg), masseter 
muscle (M), facial nerve (VII) and sternocleidomastoid muscle (SCM). Remove the 
submandibular gland. (B) Localize the digastric muscle anterior (AD) and 
posterior belly (PD). With a straight forceps, take the anterior tendon of the 
posterior belly, cut it and dissect it carefully until its origin in the tympanic bulla 
(ty). E: ear, Sg: submandibular gland, VII: facial nerve, M: masseter muscle, SMC: 
sternocleidomastoid muscle, AD: anterior belly digastric muscle, PD: posterior 
belly digastric muscle, Ty: Tympanic bulla.  
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5.  Levator veli palatini muscle (derived from the 4th branchial arch) 
 - After dissection of the posterior belly of the digastric muscle, 
localize the stylohyoid muscle, pull it laterally, and carefully 
remove it (Figure 4A). 
 - Localize the tendon of the levator veli palatini that inserts at 
the tympanic bulla (Figure 4A). Dissect it carefully and cut it on 
both sides. 
 - Look for the trachea and the esophagus that runs behind it. 
Lift the esophagus, and expose the pharynx and the larynx. 
 - Localize and dissect the area of the superior pharyngeal 
constrictor muscle. Identify the levator veli palatini and cut it at 
both sides (Figure 4B). 
 
 
 
 
 
 
 
 
 
 
 
 
  A        B 
 
Figure 4. Dissection of the levator veli palatini muscle. (A) General view after 
dissection of the digastric muscle (posterior belly). Stylohyoid muscle (St) and 
tendon of the levator veli palatini can be localized. Note the trachea (T)  and 
esophagus (Es) running behind it. (B) After lifting the trachea and the esophagus 
the pharynx (P) is exposed. The levator veli palatini that runs laterally towards the 
soft palate is now visible. The arrow indicates the dissected superior pharyngeal 
constrictor muscle; note the levator veli palatini muscles at both sides. E: ear, St: 
stylohyoid muscle, VII: facial nerve, M: masseter muscle, AD: anterior belly 
digastric muscle, PD: posterior belly digastric muscle, T: trachea, Es: esophagus, 
P: Pharynx, *levator veli palatini muscle.  
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Note: Directly after dissection, carefully remove tendon and 
connective tissue from each muscle under the stereo microscope. 
Submerge all specimens quickly in ethanol 70%, and transfer them 
to ice-cold PBS supplemented 2% P/S in a 15 ml tube. 
 
Isolation of Satellite Cells 
1. Perform the following preparation steps for SC isolation from 3 
groups of muscles: 
 -. Prepare 7.5 ml of 0.1% pronase in DMEM. Filter the solution 
through a 0.22 μm filter. Pre-warm the solution at 37°C in a 
water bath for 10 min before isolation. 
 -  Prepare 35 ml of DMEM supplemented with 10% Horse 
Serum (HS) and 1% P/S. Also pre-warm at 37°C in a water bath. 
 - Prepare 15 ml culture medium which consists of DMEM 
supplemented with 20% fetal bovine serum (FBS), 10% HS, 1% 
P/S and 1% chicken embryo extract (CEE). Pre-warm at 37°C in 
a water bath. 
 1.4. Pre-coat six plastic pipettes (10 ml) with HS and dry for at 
least 10 min before use.  
2. In the culture hood, transfer each muscle into a well of a 6-well 
plate. Using the dissection scissors, cut the muscle in small 
pieces of about 2mm. Be careful not to mince the tissue too 
much. 
3. Carefully add 2.5 ml of 0.1% pronase solution to each well and 
incubate at 37°C for 60 min. Gently shake the plate after 20, 
40, and 60 min. 
 
Note: The exact duration of the incubation depends on factors like 
age and strain of the animals. 
 
4. Monitor under the microscope. Check the muscle fragments 
and stop the enzymatic digestion when the fibers bundles get a 
loosened appearance (Figure 5). 
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5. Add 2.5 ml of DMEM supplemented with 10% HS and 1% P/S. 
Transfer to a 15 ml tube and centrifuge the tubes at 400 x g for 
5 min. Discard the supernatant by decantation. 
6. Add 5 ml DMEM supplemented with 10% HS and 1% P/S. 
Pipette the solution up and down with a 10 ml plastic pipette 
(trituration) for at least 20 times to homogenize the tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Appearance of the muscle tissue. (A) before and (B) after enzymatic 
digestion with pronase. Note that muscle bundles appear to be loosened after 
enzymatic digestion. 
 
 
7. Centrifuge the tubes at 200 x g for 4 min. Collect the 
supernatant and transfer into a 15 ml tube. 
8. Add 5 ml DMEM supplemented with 10% HS and 1% P/S. 
Pipette again with a 10 ml plastic pipette until the tissue 
fragments passes easily through the pipette. 
9. Centrifuge the tubes at 200 x g for 4 min and collect the 
supernatant in a 15 ml tube. 
10. Put a cell strainer (40 μm) onto a 50 ml tube and transfer the 
supernatant containing the dissociated cells onto the filter. 
Wash with 1 ml DMEM for maximal cell recovery. 
11. Centrifuge the tubes at 1,000 x g for 10 min and discard the 
supernatant with a pipet. 
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12. Resuspend the pellet in 300 μl culture medium and count the 
cells in a hemocytometer. 
 
Differentiation of Satellite Cells on Extracellular Matrix Gel Spots 
1. Dilute the cell suspension to obtain 1.5 x 103 cells in 10 μl of 
culture medium. 
2.  Secure the covers of the chambers slides with tape and mark 
the spots with a black marker on the bottom side of the object 
glass. 
3. Using a micropipette, put a drop of 10 μl cell suspension onto 
the extracellular matrix gel spot. Check under the microscope 
whether the drop of cell suspension has been placed correctly 
on the spot. Incubate for six hours at 37°C. 
4. Carefully add 400 μl of culture medium (DMEM supplemented 
with 20% FBS, 10% HS, 1% P/S and 1% CEE) and incubate for 
three days at 37°C. 
 
Note: At this point, freshly isolated SC are subjected to massive 
trauma (enzymatic digest and harsh trituration) and they need to 
recover. Do not disturb the cells during the first three days 37. 
Next, the culture medium can be changed depending on the type 
of experiment. The extracellular matrix gel spots can be seeded 
with a high cell density (1.5-2.5 x 103/20 μl) for differentiation 
assay. Culture medium (DMEM supplemented with 20% FBS, 10% 
HS, 1% P/S and 1% chicken embryo extract) can be replaced every 
third day. 
 
Alternatively, if expansion and passing is desired follow the next 
steps: 
− Thaw an aliquot extracellular matrix gel (500 μl) at 4°C for   at 
least 1.5 hr. Dilute 1:10 in DMEM and follow the 
recommendations in point 1.1.1. 
− Pre-chill a 10 ml pipette for 10 min at 4°C. 
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− Transfer three T75 flasks onto a cold surface (e.g. a freezer 
pack) for 10 min. 
− Use the pre-chilled pipette to put 1 ml extracellular matrix gel 
into each flask. Check that the surface is covered completely. 
Keep the flasks on the cold surface for at least another 7 min 
(Figure 1A). 
− Completely remove the remaining extracellular matrix gel with 
a 10 ml pipette, and dry the wells at 37°C for 1 hr. 
− After counting, resuspend the freshly isolated SCs in 10 ml of 
culture medium (DMEM supplemented with 20% FBS, 10% HS, 
1% P/S and 1% chicken embryo extract) and seed in the pre-
coated T75 flasks. 
− After three days, change the medium (and every third day) until 
80% confluence is reached. For passaging, wash the T75 flasks 
three times with PBS. Next add 1 ml 0.25% trypsin solution and 
incubate for three min at 37°C. Resuspend in 9 ml of culture 
medium (DMEM supplemented with 20% FBS, 10% HS, 1% P/S 
and 1% chicken embryo extract) and centrifuge at 200 x g for 5 
min. Discard the supernatant. After counting, resuspend 1 x 106 
cells in 1,000 μl of culture medium and freeze the cells. 
 
 
Representative Results 
 
Using this protocol, the masseter muscle (one side) yields 0.8-1 x 
106 cells, the digastric muscle (posterior belly) yields 1.5-2 x 105 
cells, and levator veli palatini muscle yields 1-1.5 x 105 cells. Cell 
yields depend on the muscle type, strain, and age of the animal. 
For comparison between the three muscle groups, freshly isolated 
SCs were seeded at the same cell density (1.5 x 103/10 μl). Directly 
after isolation, more than 90% of the freshly isolated cells express 
Pax7 (Figure 6).  
CHAPTER 5 
  118
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Pax7 immunostaining. Freshly isolated SCs, applied to extracellular 
matrix gel at the end of isolation (about 6 hours after initial tissue digestion). Five 
cells per field. Approximately 90% of the cells are Pax7 positive. DAPI: blue, 
Pax7: red. Scale bar, 100 μm. 
 
Day 4, 7 and 10 cultures were stained with antibodies against 
Pax7, MyoD, MyoG and MyHC immunostaining. Five arbitrary 
fields were counted per culture using a 20X objective. At day 4 
Pax7 and Myo D is expressed in all muscle groups (Figures 6 and 7 
and 8), however the progeny of SCs from the masseter and 
digastric muscles start expressing myogenin earlier than the 
levator veli palatini muscle (Figure 9). At day 10, the expression of 
MyoG is strongly reduced in all groups (Figure 9). A few days after 
seeding on the extracellular matrix gel spots, the proliferating 
cells begin to fuse and form multi-nucleated myotubes, which 
express myosin heavy chain. Small myotubes are clearly visible at 
day 7 (Figure 10). At day 10, twitching of the myotubes can be 
observed (Video1). 
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Figure 7. Pax 7, MyoD immunostaining. Day 4, 7 and 10 cultures were stained 
with antibodies against Pax7, and MyoD immunostaining. (A–C) and (D–F) 
Representative photomicrographs of day 4 and 7 cultures from the masseter 
muscle. (G and H) The number of Pax7+ and MyoD+ nuclei per microscopic field 
was counted and expressed as a percentage of the total number of nuclei (DAPI). 
DAPI: blue, Pax7: red, and MyoD: green. Scales bar, 100 μm. 
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Figure 8. Distribution of Pax7±/MyoD± in cultures from mononucleated cells in 
cultures from masseter, digastric and levator veli palatini muscle. (A–C) Day 4, 7 
and 10 cultures were stained with antibodies against Pax7, and MyoD 
immunostaining. The total number of cells is based on of the total number of 
nuclei (DAPI). (D) Data quantification of Pax7±/MyoD± cells. 
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Figure 9. Myogenin immunostaining. Day 4, 7 and 10 cultures were stained with 
antibodies against Myogenin. (A–D) Representative photomicrographs of day 4 
and 7 cultures from the levator veli palatini muscle. (E) The number of MyoG+ 
nuclei per microscopic field was counted and expressed as a percentage of the 
total number of nuclei (DAPI). (F) Data quantification of MyoG+ cells. DAPI: blue, 
Myogenin: green. Scales bar, 100 μm. 
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Figure 10. Myosin Heavy Chain immunostaining. Day 4, 7 and 10 cultures were 
stained with antibodies against myosin heavy chain (MyHC). Representative 
photomicrographs of day 4, 7 and 10 cultures from the digastric (DIG) muscle. At 
day 7, small myotubes are present while at day 10 long and well-organized 
myotubes are evident. Scales bar, 200 μm. 
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Video 1. Myotube twitching.  Examples of two representative 
fields with twitching myotubes are shown for day 10 cultures 
from digastric muscle. Video link can be found here: 
http://www.jove.com/video/52802/isolation-characterization-
satellite-cells-from-rat-head 
 
 
Discussion 
 
SCs from different branchiomeric head muscles were isolated from 
one 9-week-old Wistar rat and cultured directly on extracellular 
matrix gel spots without prior expansion and passaging. After 
isolation, the cells were counted and seeded at the same cell 
density. For the parallel isolation of three different muscles, this 
method takes about 4 hr. To avoid culture contamination, a critical 
step is the rapid washing in alcohol 70% after dissection of the 
muscles. 
During SC isolation it is important to cut the muscle tissue into 
small pieces (about 2 mm) but avoid too much mincing as this will 
result in a small cell yield because of cell damage. Also, the 
duration of the enzymatic digestion must be checked carefully 
under the microscope to avoid further damage. The aim of the 
digestion is to dissociate the myofibers. Since more than 90% of 
the isolated cells express Pax7, no further purification is required 
(Figures 6-8). This avoids extra purification steps in other methods 
such as pre-plating on uncoated dishes,14,37,38 fractionation on 
Percoll,39,40 or fluorescent- or magnetic cell sorting.41,43 For 
trituration it is essential to induce shear between the tissue 
fragments and the opening of the pipette tip as this allows the 
mechanical release of the SCs. If the trituration with a 10 ml 
pipette (inside diameter tip: 1 mm) is difficult, a 5 ml (inside 
diameter tip: 2 mm) pipette can be used first. Alternatively, glass 
Pasteur pipettes can be cut at the desired diameter and be used. 
This method is simple, efficient and allows the simultaneous 
isolation of SC from different muscle samples. 
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The culture plates for SCs can also be coated with gelatin or 
collagen, but our previous studies show that extracellular matrix 
gel is far better for the maintenance of the myogenic potential 
than collagen.38 The extracellular matrix gel spots of millimeter 
size (10 μl/Ø 2 mm or 20 μl/Ø 4 mm) allows the study of 
proliferation and differentiation of SCs with limited numbers of 
cells. For the differentiation assay about 8 to 20 times fewer cells 
are required compared to a 24-well plate (Ø 15.6 mm), and about 
80 to 200 times fewer compared to 35 mm Petri dishes (Ø 35 
mm).14,38 
Since extracellular matrix gel is expensive, this method is also 
more cost-efficient. In addition, the chamber slides can be 
replaced by plastic cover slips to further reduce the costs. For the 
preparation of the extracellular matrix gel spots overnight drying 
of the chamber slides is essential. As the extracellular matrix gel 
spots are transparent, it is necessary to mark the spots at the 
bottom side using back lighting. The chambers slides are fixed in 
a Petri dish for easy manipulation. Further cell culture expansion is 
not necessary, which offers the possibility to study the SCs of 
smaller muscles or small muscle samples. Alternatively, e.g. for 
PCR or muscle constructs if more cells are needed, the freshly 
isolated SCs can first be expanded in T75 flasks as indicated 
above. 
SCs isolated using this protocol are not suitable for further 
purification with flow cytometry immediately after isolation. The 
digestion with pronase causes extensive digestion of the surface 
antigens.14 Horse serum and fetal bovine serum that are used for 
cell culture must first be properly characterized before isolation, as 
different lot numbers differentially affected myoblasts proliferation 
and differentiation.  
In recent years, there is a growing interest in the muscles 
derived from the branchial arches and the head mesoderm (e.g. 
the extraocular muscles).24 It has been clearly demonstrated that 
head and limb muscles possess highly different properties. 
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Masseter muscle from old animals seems to retain their 
regenerative capacity in comparison with limb muscles.25,26 SCs 
from the extraocular muscles possess a robust proliferation and 
differentiation capacity comparable to SCs from head muscles, 
and show a larger engraftment potential than limb muscle SCs.24 
The fiber type distribution and myosin composition varies among 
muscle groups and also between species. Muscles originating 
from the first branchial arch in humans contain both slow and fast 
fibers (subtypes IIA and IIX), neonatal myosins and myosins typical 
for developing cardiac muscle. In rodents these muscles contain 
about 95% fast fibers myosin IIA and IIb).44-46 Studies on avian 
muscles show that SCs from different muscle fiber types vary in 
differentiation capacity. SCs from fast fibers only differentiate into 
fast muscle fibers, while SCs from slow fibers can differentiate into 
both fiber types.47 In addition, the percentage of SCs in fast 
muscle fibers is lower than in slow muscle fibers.48,49 This indicates 
that the fiber type distribution must be taken into account for 
studies on muscles in the craniofacial area. Similar to cleft palate 
muscles, the levator veli palatini muscle in rodents contains almost 
exclusively fast fibers.50 For that reason, SCs from the levator veli 
palatini are suitable for pre-clinical studies in the field of cleft 
palate. 
This protocol offers new possibilities to study SCs derived from 
branchiomeric head muscles or other smaller muscles or smaller 
muscles samples. This will facilitate the development of new 
therapies to improve the regeneration of muscles in the 
maxillofacial area in conditions such as cleft palate but also in 
other conditions affecting smaller muscles.  
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 Abstract 
Although palatal muscle reconstruction in patients with cleft 
palate takes place during early childhood, normal speech 
development is often not achieved. We hypothesized that the 
intrinsic properties of head satellite cells (SCs) and the young age 
contribute to the poor muscle regeneration after surgery. First, 
the fiber type distribution and the expression of SC markers in ex 
vivo muscle tissue from head (branchiomeric) and limb (somite-
derived) muscles from neonatal (2-week-old) and young (9-week-
old) rats were studied. Next, SCs isolated from these muscles were 
cultured for 5, 7 and 9 days. Next, we investigated the in vitro 
expression of SC markers, and calculated the proliferation, early 
differentiation, and fusion index (myotube formation).  
Ex vivo, virtually all myofibers in both masseter and levator veli 
palatini muscles contained fast myosin heavy chain (MyHC), while 
only a small percentage of digastric and extensor digitorium 
longus myofibers contained slow MyHC. This was independent of 
age. More SCs were found in muscles from neonatal rats 
compared with young rats (17.6±3.8 vs 2.3±1.6%, p<0.0001). In 
vitro, young branchiomeric head muscle (BrHM) SCs proliferated 
longer and differentiated later than limb muscle SCs. No 
differences were found between SC cultures from the different 
BrHM. SC cultures from neonatal muscles showed a much higher 
proliferation index than those from young animals at day 5 (0.8 vs 
0.2, p<0.001). In contrast, the fusion index in neonate SCs was 
about twice as low as in SCs from young muscles at day 9 
(27.6±1.4 vs 62.8±10.2, p<0.0001). 
In conclusion, SCs from BrHM differ from limb muscles especially 
in their delayed differentiation. SCs from neonatal muscles form 
myotubes less efficiently than those from young muscles. These 
age-dependent differences in stem cell properties urge careful 
consideration for future clinical application in patients with cleft 
palate deformity. 
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The soft palate is the posterior muscular extension of the hard 
palate and its proper functioning is vital for normal speech, 
swallowing, blowing and sucking. About 1:500 to 1:1,000 newborns 
have a cleft in the lip and/or palate, which makes this the most 
common congenital craniofacial malformation in humans.1 If a cleft 
in the soft palate is present, the palatal musculature is disorganized 
and abnormally inserted into the bony palate. Hence, surgical 
reconstruction of the muscle sling is required to improve the 
function. However, velopharyngeal dysfunction persists in 7 to 30% 
of the treated patients and deficiencies in speech are common.1-3 
Several factors contribute to the poor outcome of surgery but 
fibrosis seems to be an important factor.4, 5  
Muscle progenitors, the satellite cells (SCs) are located between 
the basal lamina and the plasmalemma of the myofiber.6 Following 
muscle injury, these cells become activated, proliferate and then 
differentiate into myoblasts. Differentiating myoblasts can then fuse 
to form new myofibers or repair damaged ones. Quiescent SCs 
express the transcription factor Pax7,7 while their progeny, the 
proliferating myoblasts, additionally express the myogenic 
determination factor 1 (MyoD).8 Differentiating myoblasts express 
myogenin (MyoG).9 The terminal differentiation of myoblasts is 
marked by their fusion into myofibers and the expression of muscle-
specific proteins such as myosin heavy chain (MyHC).8, 9  
Soft palate muscles originate from the branchial arches and differ 
from somite-derived skeletal muscles (trunk, limb, ventral 
pharyngeal and tongue muscles).10 Branchiomeric head muscles 
(BrHM) are known to regenerate slower and develop more fibrous 
connective tissue after injury when compared to limb muscles.11 We 
previously demonstrated that SCs in injured palatal muscle do 
migrate to the site of injury but fail to form new myofibers. We 
hypothesized that not only fibrosis but also the intrinsic properties 
of head SCs account for the poor regeneration of palate muscles 
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after injury. First, the fibre type distribution and the expression of 
SC markers were studied in ex vivo muscle tissue. Next, we 
investigated the in vitro expression of SC markers, and calculated 
the proliferation, early differentiation and fusion index (myotube 
formation) of SCs isolated from representative muscles originating 
from the 1st, 2nd and 4th branchial arches. These muscles were, 
respectively, masseter (Mass), digastric (Dig) and levator veli 
palatini (LVP) were included. As a reference, SCs from the somite-
derived extensor digitorum longus (EDL) muscle of the limb were 
analyzed. Since the repair of a soft palate cleft usually takes place 
in early childhood age may also be an important determining factor. 
Hence, we performed all studies in neonatal (2-week-old) and 
young (9-week-old) rats.  
 
Material and Methods 
 
Animals 
The protocol was approved by the local board for animal experiments 
(Dier Experimenten Commissie, DEC) from the Radboud University 
Nijmegen in accordance with Dutch laws and regulations (RU-DEC 
2013-205). Twelve male Wistar Unilever rats (Harlan BV, Horst, The 
Netherlands) of 2- and 9-weeks old (neonatal and young rats 
respectively). were housed under standard laboratory conditions.  
 
Experimental procedures 
Dissection of the superficial head of the Mass, Dig and LVP muscles 
was performed in the animals as previously described.12 For the 
dissection of the EDL muscle from the same animals, the skin of the 
lower limb of the animals was shaved and removed to expose the 
underlying muscles. Then, the distal tendon of the tibialis anterior and 
EDL was cut after which the EDL was identified and isolated by cutting 
the proximal tendon. All the muscles were harvested for 
immunohistochemistry (n=3, for each age group) or cell culture (n=3, 
for each age group). 
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Immunohistochemistry 
Dissected muscles were fixed in 4% paraformaldehyde in phosphate 
buffered saline (PBS) and processed for paraffin embedding. The 
specimens were sectioned transversally (Figure 1) and stained as 
described previously in detail.13 The following primary antibodies were 
used: mouse anti-fast MyHC (1:5000; Sigma Chemical Co, Zwijndrecht, 
The Netherlands), mouse anti-slow MyHC (1:5000; Sigma Chemical 
CO), mouse anti-Pax7 (1:100; Developmental Studies Hybridoma Bank 
(DSHB), Iowa City, IA, USA), mouse anti-MyoD (1:50; DAKO, 
Dakopatts, Glostrup, Denmark), and mouse anti-myogenin (MyoG; 
1:100; DSHB). 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of head and limb in rats. Left: ventral view 
of the head. The dashed lines indicate the level of sectioning for superficial 
masseter (Mass), digastric (Dig) and levator veli palatini (LVP) muscles. Right: 
lateral view of a hind limb. The dashed line indicates the level of sectioning 
for the extensor digitorium longus muscle (EDL). 
 
Satellite cell isolation 
After dissection, SCs were isolated from the EDL and branchiomeric 
muscles (Mass, Dig and LVP) obtained from 2- and 9-weeks old rats 
following a protocol described previously.12 Briefly, the tissue was 
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minced and treated with 0.1% Pronase for 1 h at 37°C (with gentle 
swirling every 20 min) followed by vigorous trituration to release 
cells from the muscle bulk. The cell suspensions were filtered 
through cell strainers (70 μm) and cells were then harvested by 
centrifugation at 1000×g for 10 min. Freshly isolated cells were 
incubated in tissue culture flasks coated with 1 mg/mL Matrigel and 
cultured for three days at 37°C. At day 4, cells were trypsinized and 
used for further culture experiments. This method of isolation yields 
> 90% of Pax7-positive cells at day 0.12 
 
Cell culture and differentiation of satellite cells 
As described previously,12 for each muscle group, SCs were seeded 
at the same cell density (2 x 103/20μL) on Matrigel spots (1mg/ml) 
in chamber slides. Next, culture medium (Dulbecco's modified 
Eagle's medium with 4,500 mg/L glucose, 4 mM L-glutamine, and 
110 mg/ml sodium pyruvate supplemented with 20% fetal bovine 
serum, 10% horse serum, 1% penicillin-streptomycin and 1% 
chicken embryo extract) was added. Next, cell cultures were 
incubated at 37°C in a humidified tissue culture incubator. Medium 
was replaced every other day. At days 5, 7, and 9 after seeding, 
cells were washed with DMEM and fixed in 2% formaldehyde for 10 
min.  
 
Immunofluorescense staining of satellite cell cultures 
Fixed cell cultures were washed with PBS and permeabilized with 
0.5% Triton X-100 in PBS for 10 min. The cells were washed again 
with PBS and then incubated in blocking buffer containing 1% of 
normal goat serum for at least 24 hours. After washing with TRIS-
buffered saline, cells were incubated with a mouse anti-Pax7 (1:50; 
DSHB, Iowa City, CA, USA), mouse anti-MyoG (F5D, 1:200; DSHB), 
rabbit monoclonal anti-MyoD1 (EP212, 1:100, Cell Marque) or 
mouse monoclonal anti-MyHC (MF20, 1:500). Secondary antibodies 
used were goat-anti-mouse IgG Alexa Fluor 594 and goat-anti-
rabbit IgG Alexa Fluor 488 (Both Invitrogen, 1:1000 dilution). 
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Quantification 
For the analysis of immunohistochemical sections and 
immunofluorescence cell staining ImageJ14 was employed to 
facilitate manual counting of type I and II muscle fibers or cells 
within 9 muscle cross-sections from 3 different rats. Muscle cross-
sections contained at least 400 to 500 muscle fibers and/or cells 
(10x magnification). For the analysis of primary cell cultures, five to 
ten arbitrary fields of each culture were counted at 10x or 20x 
magnification, depending on overall cell density at the time point 
of interest (a minimum of 200 cells were counted). For each cell 
marker, nine wells from three independent experiments were 
quantified. The data are expressed as the mean percentage ± SD 
of the total number of nuclei as indicated in the figure legends. For 
de index ratios, we used automatic counting of double stained 
pictures with ImageJ. The proliferation index was defined as the 
number of nuclei positive for both Pax 7 and MyoD (Pax7+ and 
MyoD+) divided by the total of Pax7+ cells. The early differentiation 
index was defined as the number of nuclei positive for both MyoD 
and MyoG (MyoD+ and MyoG+) divided by the total of MyoD+ 
cells. The fusion index was defined as the number of nuclei within 
myotubes expressed as the percentage of total nuclei present in 
each image. 
 
Statistics 
All date was analyzed by one- or two-way ANOVA with Sidak or 
Tukey post-hoc test using GraphPad Prism version 6.00 for MacXOS 
(GraphPad Software, San Diego, CA, USA, www.graphpad.com). 
For all experiments, unless otherwise noted, p-values of less than 
0.05 were considered significant. 
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Results 
 
Immunohistochemical analysis of muscle tissue 
Fiber type composition  
Mass, Dig, LVP and EDL tissue sections from neonatal and young 
animals were stained for slow and fast MyHC (Figure 2). Mass and 
LVP muscles contained only fast myofibers. Although the majority 
of myofibers in Dig and EDL muscles were fast myofibers, also a 
small portion of slow myofibers could be observed (5.8±1.1% and 
2.8±0.6% respectively). No significant difference in the number of 
slow myofibers between neonatal and young animals were found. 
 
Pax7, MyoD and MyoG-positive cells ex vivo 
Muscle sections were stained with antibodies against Pax7, MyoD 
and MyoG. In general, more Pax7+ cells were found in muscles from 
neonatal rats compared with young rats (17.6±3.8 vs 2.3±1.6%, 
p<0.001). Mass and LVP muscles contain significantly larger number 
of Pax7+ (Figure 3 and 5A) MyoD+ and MyoG+ cells than limb 
muscles in both neonatal and young animals. In neonates, the 
percentage of Pax7+ cells in Mass (20.5±4.5%) and LVP (21.3±7.4%) 
was higher than in both Dig (13.9±2.3%) and EDL (14,9±3,4%) 
(p<0.05). Also in young animals, the percentage of Pax7+ cells in 
Mass (3.9±0.7%) and LVP (3.5±0.8%) was significantly higher than 
in Dig (1.0±0.4%) and EDL (0.7±0.1%) (p<0.05, Figure 3 and 5A). 
Similarly, in both neonates and young animals, the percentage of 
MyoD+ cells was higher in Mass and LVP as compared to both Dig 
and EDL (p<0.05, Figure 4 left and 5B). Finally, in neonates the 
percentage of MyoG+ cells in Mass (14.4±5.2%) and LVP 
(14.9±3.0%) were higher than in both Dig (9.81±2.2%) and EDL 
(Figure 4 right and 5C). All neonatal muscles contained significantly 
larger number of Pax7+, MyoD+, and MyoG+ cells compared with 
young muscles (p<0.0001). 
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Figure 2. Fast and slow myosin heavy chain staining of muscles. Sections from the 
masseter (MASS), digastric (DIG), levator veli palatini (LVP), and extensor 
digitorium longus (EDL) muscles were stained with antibodies against slow and fast 
myosin heavy chain. Representative tissue sections of young animals are shown. 
Dig and EDL muscles contain mainly fast myofibers, and a small percentage of slow 
MyHC. In MASS and LVP muscles slow myofibers are virtually absent. No 
differences were found between neonatal and young muscles. Note that the 
proportion of each fiber type, however, varies between muscles and even in 
different regions of the same muscle, which reflects its functional demands. Scale 
bar, 200 μm.  
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Figure 3. Pax7 positive cells ex vivo. Sections from the superficial head of the 
masseter (MASS), digastric (DIG), levator veli palatini (LVP), and extensor 
digitorium longus (EDL) muscles were stained with antibodies against Pax7 
(positive cells in brown). Representative sections of neonatal and young muscles 
are shown. Note that the number of satellite cells (cells in brown) is higher in Mass 
and LVP than in DIG and EDL in both neonatal and young muscles. Scale bar, 100 
μm.  
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Figure 4. MyoD and MyoG positive cells ex vivo. Sections from the superficial head 
of the masseter (MASS), digastric (DIG), levator veli palatini (LVP), and extensor 
digitorium longus (EDL) muscles were stained with antibodies against MyoD and 
MyoG (positive cells in brown). Only representative sections of neonatal muscles 
are shown. Note that the number of of MyoD and MyoG positive cells are higher 
in MASS and LVP muscles. Scale bar, 100μm.  
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Figure 5. Pax7, MyoD and MyoG positive cells quantification ex vivo. The 
percentage of cells positive for Pax7 (A), MyoD (B), and MyoG (C) was determined 
as a percentage of the total number of nuclei per microscopic field. (expressed as 
mean ± SD). N: neonatal, Y: young. *Significant difference between muscles (p< 
0.05); #significant difference between young and neonatal animals (p< 0.0001).   
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Pax7, MyoD and MyoG-positive cells in vitro 
Isolated SCs from Mass, Dig, LVP and EDL from both neonatal and 
young animals were cultured on Matrigel spots. The primary cell 
cultures were fixed on days 5, 7 and 9 after isolation, and stained 
with markers for SCs (Pax7, MyoD, and MyoG) and MyHC. 
Subsequently, the percentage of Pax7+, MyoD+, MyoG+ cells was 
calculated. Next the proliferation, early differentiation, and fusion 
index was determined. 
 
Pax7-positive cells 
In cell cultures from neonates, a higher percentage of Pax7+ cells 
was found in Mass, Dig and LVP (92.0±1,6%, 90.9±4.1%, and 
90.1±2.6% respectively) at day 5 compared with EDL cell cultures 
(74.6±2.1%, p<0.05, Figure 6A). At day 7, the number of Pax7+ cells 
in all cultures had significantly reduced by more than half. The 
percentage of Pax7+ cells in these cultures was still higher than in 
EDL (8.7±1.2, p<0.05, Figure 6A). Only few SCs were present in all 
cultures at day 9. The data for young animals are shown in Figure 
6B. About 40% of the cells were Pax7+ at day 5. At day 7, this 
percentage was maintained in Mass, Dig, and LVP (43.6±2.0, 
43.2±4.1, and 47.5±3.6 respectively) cell cultures but not in the EDL 
(17.1±4.6%, p<0.05). Only few Pax7+ cells were present at day 9. 
All cell cultures from neonates showed a higher percentage of 
Pax7+ cells than cultures from young animals at day 5 (p<0.0001). 
 
MyoD-positive cells 
In cell cultures from neonates, a higher percentage of MyoD+ cells 
was found in Mass, Dig and LVP (62.2±7.2%, 58.9±6.3%, and 
60.7±7.0% respectively) at day 5 compared with EDL (42.7±2.4%, 
p<0.05, Figure 6C). At day 7, the number of MyoD+ cells was 
significantly reduced by about half. The percentage of MyoD+ cells 
in Mass, Dig, and LVP cell cultures (32.8±4.5%, 26.2±3.6%, 
31.5±1.5% respectively) was still higher than in EDL cell cultures 
(11.2±1.5%, p<0.05, Figure 6C). Only few MyoD+ cells were 
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present at day 9. For young animals, the data are shown in Figure 
6D. About 40% of the cells were MyoD+ cells at day 5. This 
percentage was maintained in Mass, Dig, and LVP (48.5±9.2, 
43.7±2.1, 47.1±3.0 respectively) at day 7 but not in the EDL cell 
culture which was significantly decreased (28.3±8.0%, p<0.05). 
Only few MyoD+ cells were found at day 9. As the case for Pax7+ 
cells, all cell cultures from neonates showed a higher percentage of 
MyoD+ cells than cultures from young animals at day 5 (p<0.0001). 
 
MyoG-positive cells  
Overall, a small percentage of MyoG+ cells was present in cell 
cultures from neonates at days 5, 7, and 9 (Figure 6E). The highest 
percentage of MyoG+ cells was found at day 7 (p<0.05). The 
percentage of MyoG+ cells for young animals is shown in Figure 6F. 
A small percentage of MyoG+ cells were found at day 5. In contrast, 
about 40% of the cells MyoG+ cells at day 7. A higher percentage 
of MyoG+ cells was found in cell cultures from EDL (54.9±7.1%) at 
day 7 compared with Mass, Dig, and LVP cell cultures (39.6±6.4%, 
38.8±8.9%, 38.1±7.2% respectively, p<0.05). No significant 
differences were found at day 9. Few number of MyoG+ cells were 
found at day 9. Cell cultures from young animals showed a higher 
percentage of MyoG+ cells than those from neonatal animals at day 
7 (p<0.0001). 
 
 
 
 
 
 
 
 
  
NEONATAL SATELLITE CELLS FORM SMALL MYOTUBES  
 145 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Satellite cell staining in vitro. Day 5, 7 and 9 cell cultures were stained 
with antibodies against Pax7, MyoD and MyoG. The number of Pax7+ (A, B) 
MyoD+ (C, D) and MyoG+ (E, F) nuclei per microscopic field was counted and 
expressed as a percentage of the total number of nuclei (DAPI+). N: neonatal, Y: 
young. The effect on time was significant between days 5 and 7 in A, C, E and F, 
between days 7 and 9 (p<0.05) in all groups, and between days 5 and 9 in A, B, C, 
D, E and F only for the head muscles. *Significant difference between muscle 
groups (p< 0.05).  
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Proliferation index 
Cell culture from neonates and young animals were co-stained with 
antibodies against Pax7 and MyoD to determinate the proliferation 
index. The proliferation index (double positive cells divided by total 
Pax7+ cells) for both neonatal and young cell cultures are shown in 
figure 7A and 7B. In cell cultures from neonates, a higher index was 
found in all muscles at day 5 (0.8±0.1 Vs 0,2±0.1). This index had 
decreased by more than half at day 7. The proliferation index was very 
low at day 9 (Figure 7A). There were no differences between the 
muscle groups. In contrast, the index for all young cell cultures, was 
about 0.3 at day 5. This was maintained in all muscles except by the 
EDL at day 7, which shows a significant decrease (0.096±0.083, 
p<0.05, Figure 7B). The proliferation index was low at day 9. All cell 
cultures from neonates showed a higher proliferation index than 
cultures from young animals at day 5 (p<0.0001). 
 
Early differentiation index 
Cell culture from neonates and young animals were co-stained with 
antibodies against MyoD and MyoG to determinate the differentiation 
index. The differentiation index (double positive cells divided by total 
MyoD+ cells) for both neonatal and young cell cultures are shown in 
figure 7C and 7D. Overall, the index was low in cell cultures from 
neonates at days 5, 7, and 9 (Figure 7C). In young cells cultures, an 
index of about 0.3 was found at day 5 and 7. There were no significant 
differences between the muscle groups. The index was very low at day 
9 (Figure 7D). Cell cultures from young animals showed a higher index 
than those from neonatal cell cultures at all time points (p<0.0001). 
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Figure 7. Proliferation and early differentiation index in vitro. (A and B) Day 5, 7 
and 9 cell cultures were co-stained with antibodies against Pax7 and MyoD. The 
proliferation index was defined as the number of double positive cells divided by 
the total of Pax7+ cells. (C and D) Day 5, 7 and 9 cell cultures were co-stained with 
antibodies against MyoD and MyoG. The early differentiation index was defined 
as the number of double positive cells divided by the total of MyoD+ cells. 
*significant difference between the muscle groups (p< 0.05). Differences between 
the time points are indicated by letters (p<0.0001); groups with the same letter are 
not significantly different, groups with a different letter are significantly different. 
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Myotube formation 
To evaluate myotube formation, cell cultures were stained with 
antibodies against fast MyHC. To evaluate myotube formation, cell 
cultures were stained with antibodies against fast MyHC. The 
number of fused nuclei in myotubes is expressed as fusion index in 
figure 8. In general, all SC cultures from both neonatal and young 
animals showed myotube formation at day 7. In neonates, no 
differences were found at any time point (Figure 8B). In young 
animals, no significant differences were found at day 5. EDL cell 
cultures (40.8±6.0%) showed a higher fusion index compared with 
Mass, Dig and LVP at day 7 (24.0±4.5%, 22.7±3.5%, and 25.6±5.2% 
respectively, p<0.05). In contrast, the fusion index from Mass, Dig, 
and LVP (70.6±3.7%, 65.8±8.5%, and 67.0±10.4% respectively) was 
higher than from EDL cell cultures at day 9 (47.8±7.9%, p<0.05, 
Figure 8B). The fusion index in cells from young animals was about 
twice as high (P<0.0001) compared with cells from neonates. 
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Figure 8. Myosin heavy chain staining in neonatal and young satellite cell in vitro. 
Day 5, 7 and 9 cell cultures were stained with antibodies against myosin heavy 
chain. (A) Representative microscopic fields of day 5 and 9 cultures from the 
masseter muscles from neonates and young animals. Scale bar,200 μm. (B) Fusion 
Index. The fusion index is determined as the percentage of nuclei lying inside the 
myotubes compared to the total number of nuclei per microscopic field (expressed 
as mean ± SD). The effect of time was significant between days 5, 7, and 9 in all 
groups *Significant difference (p< 0.05). 
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 Discussion 
 
In a previous study, we demonstrated that muscle regeneration in the 
soft palate of the rat after excisional injury is incomplete.5 Extensive 
fibrotic tissue developed in the wound area with little or no formation 
of new myofibers. SCs did proliferate and migrate into the wound area, 
but failed to form new myofibers probably because large amounts of 
collagen had been deposited. The present study aimed to determine 
whether also the intrinsic properties of BrHM SCs contribute to 
impaired muscle regeneration in the soft palate. We compared the in 
vitro capacity for differentiation and myotube formation of BrHM SCs 
and limb muscle SCs in neonatal and young animals. Representative 
muscles originating from the 1st (Mass), 2nd (Dig), and 4th (LVP) branchial 
arches are compared. 
The fiber type distribution and myosin composition varies 
between muscles and even in different regions of the same muscle, 
which reflects their functional demands. Muscles originating from 
the first branchial arch in humans contain both slow and fast fibers, 
neonatal myosins and myosins typical for developing cardiac 
muscle. In rodents these muscles contain about 95% fast fibers,15,16 
as is also the case for all muscles included in this study. The fiber 
type composition of head and limb muscles in our study is 
comparable. In addition, the percentage of SCs in fast muscle fibers 
is lower than in slow muscle fibers.17 Hence, the ex vivo and in vitro 
differences found in our study might be related to embryological 
origin rather than fiber type composition. Similar to cleft palate 
muscles in humans, the LVP in rodents contains almost exclusively 
fast fibers.13 Myoblasts from slow muscles do not express slow 
MyHC when there is no innervations such as during cell culture.18 
We demonstrated that the number of SCs in Mass and LVP is 
higher than in EDL muscles in both neonatal and young animals. A 
higher number of SCs has also been demonstrated in other BrHMs 
from the rat such as the pharyngeal muscles compared with somite-
derived muscles.19 Also in humans, a higher number of SCs in young 
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adult Mass compared with young adult biceps has been reported.20 
The higher SC density observed in BrHMs seems to represent the 
higher turnover rate of these muscles compared with limb muscles 
under basal conditions.19, 21, 22 A continuous cycle of injury and 
regeneration, as shown for the laryngeal muscle in humans, could 
be responsible for the high SC density in these muscles.23 
As expected, neonatal muscles show a higher percentage of 
proliferating SCs compared with young muscles. This suggests that 
the SCs from muscles from young rats are largely quiescent because 
the demands for muscle growth are lower than in neonatal animals. 
In rodents, SCs comprise approximately 35% of all muscle nuclei at 
birth, which decreases to 10% at 4 weeks of age and less than 5% 
at sexual maturity when the cells are largely mitotically 
quiescent.24,25 Many of these SCs are proliferating (about 80%) in 
growing muscle until a population of quiescent SCs is established 
in mature muscle.25  
In general, there were no differences in the proliferation and early 
differentiation index between the SCs derived from the different 
branchial muscles. We did show that BrHM SCs proliferate longer 
in culture than SCs from limb muscles. EDL SCs isolated from young 
muscles seems starting to differentiate earlier than BrHM SCs 
resulting in a higher fusion index at early time points. However, if 
BrHM SCs are cultured for a longer time they exhibit a higher fusion 
index than EDL SCs. This was also reported by others.26, 27 The 
longer proliferation phase of BrHM SCs might allow the deposition 
of large amounts of extracellular matrix components by fibroblasts 
in vivo. This could explain the decreased myogenic potential of 
BrHM SCs during healing.28 
It is particularly interesting that SCs from neonates only form few 
myotubes in spite of the initially high percentage of proliferating 
SCs. In the neonatal growing muscle approximately 80% of SCs 
compose a highly proliferative population, whereas the remaining 
cells hardly divide.25 In vitro and in vivo studies demonstrate that 
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these high proliferative SCs exclusively fuse with already existing 
myofibers, while the low proliferative SCs mainly fuse together.29 
This may explain the low fusion index of neonatal SCs in our 
experiments. Ample evidence suggests that growing immature 
muscles have a lower capacity for regeneration than older muscles. 
For instance, denervation-induced injuries are much more 
devastating in neonatal limb muscles than in adult muscles.30 Also, 
neonatal limb SCs seem to engraft less efficiently than their adult 
counterparts.31 This might be caused by the large highly 
proliferating fraction of SCs that is not able to participate in muscle 
repair. The low regenerative capacity of immature growing muscles 
might also contribute to the poor outcome after repair of a soft 
palate cleft. 
Muscle regeneration and soft palate function would probably be 
better if surgical closure was performed in older children. However, 
speech and language development already start early in human life, 
which requires soft palate repair to be performed as early as 
possible.32, 33 Thus, new adjuvant therapies that improve 
differentiation, fusion and myotube formation of neonatal SCs from 
immature clefted muscles are crucial to improve muscle 
regeneration and soft palate repair. Thus, new adjuvant therapies 
that improve differentiation, fusion and myotube formation of 
neonatal SCs from immature clefted muscles are crucial to improve 
muscle regeneration and soft palate repair. 
As mentioned, no in vitro differences were observed between the 
SCs from different BrHMs. However, Mass en LVP seem to have a 
larger population of Pax7+ cells in both neonatal and young 
animals. For clinical application it is important to realize that SCs 
from the Mass are much easier to harvest than from the LVP. This is 
due to the superficial localization and simple dissection of the Mass. 
Also, the Mass muscle can be accessed intraorally for harvesting, 
which does not yield a visible scar. Thus, the Mass muscle seems to 
be an ideal SC source for cell–based therapy in cleft lip and/ or 
palate repair and other craniofacial muscle reconstructions. 
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In summary, we demonstrated that not only fibrosis but also the 
intrinsic properties of SCs may be responsible for the poor 
regeneration of the palate muscles after (surgical) injury. BrHM 
differ from limb muscles especially in their delayed differentiation. 
In contrast, the SCs from muscles originating from the different 
branchial arches are highly similar. SCs from neonatal muscles have 
a lower fusion efficiency than those from older muscles suggesting 
a lower regenerative capacity. This study mainly shows the 
importance of age in muscle regeneration. Although in vitro studies 
not always exactly recapitulate the events occurring in vivo, they 
give insight into the regulation of satellite cell myogenesis. 
Therefore, further in vivo studies into age-dependent differences in 
SC properties are required to confirm this. This will provide valuable 
information for future clinical applications in young, growing 
patients. New therapies should aim to improve muscle regeneration 
after surgery by preventing fibrosis and promoting SC fusion. 
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In cleft lip and/or palate (CL/P) patients, surgical closure including 
repositioning of the muscle sling (levator palatine muscle) fails to 
restore the function of the soft palate about 7-30%. This results in 
hypernasal speech that might require additional surgical corrections 
and speech therapy.1 In spite of all efforts to accomplish adequate 
velopharyngeal function, stigmatizing speech aberrations are quite 
common in these patients.2 
Skeletal muscles generally possess a remarkable ability to 
regenerate after injury. The progenitor cells that are responsible for 
muscle regeneration are the satellite cells (SCs). 3,4 After injury, SCs 
undergo proliferation, differentiation and fusion to either form new 
myofibers or to repair damaged ones.5,6 However, regeneration of 
the soft palate muscles after surgical repair is suggested to be 
hampered because of three aspects; (1) their low intrinsic 
regenerative capacity, (2) the specific muscle properties related to 
clefting, and (3) the development of fibrosis (chapter 2).  
Muscle regeneration can be seriously impaired in different types 
of congenital degenerative diseases.7,8 Interestingly, some of the 
head muscles show a high resistance against degeneration in 
several of these degenerative diseases such as Duchenne muscular 
dystrophy.9 This suggests that head muscles differ from other 
muscles. Injuries of the head (branchiomeric) muscles heal much 
slower than similar injuries in limb (somite-derived) muscles.10 In 
addition, more fibrous connective is formed during healing 
compared to limb muscles is formed during healing. SCs from head 
muscles express a distinct profile of transcription factors including 
unique factors such as Tcf21.11 All this indicates that the physiology 
of SCs from limb and head muscles is different, and that they 
respond differently to injury.8 Over the past two decades, skeletal 
muscle tissue engineering techniques have started to develop.12,13 
In contrast to the extensive research on limb and trunk muscles, 
studies on head muscles and their regeneration are rare.  
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Patients with a cleft in the soft palate may benefit of the 
development of new therapies based on tissue engineering to 
ameliorate palatal muscle repair. Consequently, this requires both 
suitable animal models and appropriate in vitro culture systems to 
design and optimize new strategies for soft palate repair. The 
studies performed in this thesis focus on the biology and 
regeneration of branchiomeric muscles. These preclinical studies 
form the basis for the development of new therapies to enhance 
muscle regeneration in the soft palate and ultimately to improve the 
quality of life of cleft palate patients and their families.  
In the following sections our most interesting findings will be 
discussed as well as the future perspectives for research in this field.  
 
 
The animal model 
 
Firstly, we characterized the regeneration of the soft palate muscles 
in the rat after injury. We developed the first model for soft palate 
muscle regeneration by making a full-thickness defect in the soft 
palate to analyze the healing process (chapter 3 and 4). After muscle 
injury, extensive fibrotic tissue developed in the wound area with 
little or no formation of new myofibers. This model represents 
critical aspects of the clinical situation because it allows to study the 
regeneration of myofibers and the development of fibrosis. 
However, a drawback is that these animals do not have a congenital 
cleft and therefore the intrinsic abnormalities of cleft muscles are 
missing. In the future, a key factor to achieve success will be not 
only to understand muscle regeneration in the soft palate muscles 
under normal conditions, but also in cleft muscles. Before 
translation into the clinic, model systems representing clinical 
aspects of CL/P are required. The increasing knowledge of specific 
genes causing CL/P allow the development of genetically 
engineered mouse models that represent specific abnormalities of 
CL/P.14 While the use of these models have limited applications for 
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postnatal studies due to early perinatal mortality,15,16 SC isolation 
from palatal muscles of these animals offer new possibilities for the 
understanding of SC biology in syndromic CL/P cases. Additionally, 
the use of larger animal models such as the existing congenital cleft 
palate model in the goat may be necessary.17-19 
In summary, we developed a model for compromised muscle 
regeneration in the soft palate by introducing a full-thickness 
defect. This model offers promising possibilities for further 
research. Tissue processes such as collagen deposition and fibrosis 
can be studied easily. Ultimately novel strategies based on tissue 
engineering can be developed to improve the outcome of cleft 
palate surgery. However, in the future, the use of larger cleft palate 
models may be necessary as they will approach the clinical situation 
more closely.  
 
 
The in vitro model 
 
In chapter 4, we demonstrated that muscle regeneration in the soft 
palate starts with the activation, recruitment, and proliferation of 
SCs from the wound margins. Next, activated SCs migrate into the 
wound area, proliferate and differentiate into myoblasts. However, 
recruited differentiating myoblasts failed to fuse and did not form 
new myofibers within the fibrotic tissue. Was the accumulation of 
collagen impeding SC differentiation and fusion? Or do head 
muscle SCs indeed have a lower regenerative capacity as suggested 
by earlier studies? In the in vivo model it is difficult to investigate 
which specific factors cause the poor muscle regeneration. The next 
step then was to analyze the differentiation and myotube formation 
of SCs from branchiomeric head muscles (BrHM). Hence, SCs from 
BrHM needed to be isolated. However, muscles from the head area 
in the rat are small and difficult to dissect. For instance, the levator 
veli palatini muscle in the rat is not easily accessible, and its small 
size makes it difficult to isolate the SCs. In order to obtain enough 
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SCs for in vitro studies, either the cells need to be expanded or 
larger numbers of animals are required. However, the expansion of 
primary SCs can seriously limit their proliferative and regenerative 
capacity.20 With this in mind, we developed a new method (chapter 
5) for the isolation and culture of SCs from head muscles of young
rats. After isolation, low numbers of SCs are cultured on
extracellular matrix spots of millimeter size to study their
proliferation and differentiation. This approach not only avoids the
expansion and passaging of SCs but also reduces the number of
animals required.
As mentioned before, muscle regeneration in the soft palate of 
the rat after excisional injury is incomplete. Differentiating SCs 
within the wound area failed to form new myofibers as large 
amounts of collagen are deposited. However, also the capacity of 
BrHM SCs to form myofibers might be impaired. In order to clarify 
this, in chapter 6, we investigated the differentiation and myotube 
formation of SCs isolated from muscles originating from the 1st, 2nd 
and 4th branchial arches. We also compared these cells with limb 
muscle SCs. Two age groups were included, neonatal (2-weeks old) 
and young rats (9-weeks old) to evaluate the effects of age.  
We confirmed earlier observations that differentiation of BrHM 
SCs is delayed when compared with muscles from the limb. This 
delay in differentiation might explain the poor regeneration of 
BrHM in response to injury. We also demonstrated that SCs from 
neonatal muscles only form few and small myotubes suggesting 
age-dependent differences in SCs properties.  
There is also evidence that immature growing muscle and full 
growth muscle behave quite different. For instance, insulin-like 
growth factor 1 has a hypertrophic effect on skeletal muscle only 
during muscle growth.21 Also, the sarcolemma of an actively 
growing myofiber seems to respond differently to injury. The 
vesicle-mediated membrane resealing in injured adult muscle is less 
evident in injured growing muscle.22,23 In addition, other differences 
such as calcium regulation, membrane fluidity, and lipid 
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composition have been reported.24 Thus, the distinct properties of 
growing muscle may have large implications for the development 
of muscle therapies in children. 
A limitation of this model is that the cells are grown on solid flat 
surfaces as a two-dimensional (2D) monolayer. In contrast, a three-
dimensional (3D) cell culture offers an artificial environment in which 
cells are able to grow in all three directions. Cells in a 3D 
environment compared to 2D environment, show improved 
viability, morphology, proliferation, and differentiation.25-27 
Therefore, 3D cell culture systems mimics more accurately the in 
vivo situation compared to 2D cell culture systems.28 
In addition, efforts to gain insight into the cellular mechanisms of 
human diseases have resulted in the development of cellular 
disease models. In these models, human cells, including primary 
cells, established cell lines and more recently, derivates of induced 
pluripotent stem cells are cultured. In fact, the ability to generate 
patient-specific induced pluripotent stem cells offers modeling 
human disease and individualized drug testing.29,30 Although this 
field is not yet fully developed, there are already some examples of 
major success in personalized medicine, recapitulating key features 
of human disease in vitro. For example, a human congenital heart 
syndrome was recently modeled and further employed to evaluate 
drugs that may ameliorate the disease phenotype.30 Fortunately, 
the rapid advances in this field promise further applications. In the 
future, 2D or 3D human cultures of cleft palate muscles might reflect 
both the genetic background and phenotype of CL/P for a specific 
patient. Hence, these systems could be not only used to mimic 
disease but also for the testing of regenerative medicine 
approaches and personalized medicine.31-33 An important 
challenge, however, is the possibility to incorporate these personal 
systems in a routine clinical laboratory setting.33 
In summary, we developed a rapid and economical method for 
the isolation and study of SCs derived from head muscles or small 
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muscle samples. We demonstrated that not only the presence of 
fibrosis, but also the intrinsic properties of SCs as well as age-
depended differences in stem cell properties determine the 
regeneration of palate muscles after injury. Further studies must be 
focused on clinical application in growing CL/P patients. However, 
the transition toward 3D culture systems using specific genetically 
engineered cells is required. Hopefully in the future, novel 
humanized models for CL/P will be available.  
Regenerative strategies for cleft palate repair 
In vivo and in vitro results show that both fibrosis and intrinsic 
characteristics of BrHM SCs contribute to impaired muscle 
regeneration after injury (chapter 4 and 6). New therapies aimed at 
preventing fibrosis and promoting myofiber formation are crucial to 
improve muscle regeneration after soft palate repair. Extracellular 
matrix components, growth factors, and cytokines may be used to 
address both problems.  
Muscle fibrosis is induced by transforming growth factor-1 (TGF-
1) and myostatin, both members of the TGF- super family of 
growth factors.34 TGF-1 plays a significant role in the initiation of 
fibrosis by inducing myofibroblast differentiation,34 while myostatin 
reduces the migration of SCs and also their proliferation and 
differentiation.35,36 Therefore, the inhibition of TGF-1 and 
myostatin activity may prevent fibrosis and improve muscle healing 
after injury.35 Decorin is a member of the small leucine-rich 
proteoglycan family, which binds TGF-1 and myostatin thereby 
reducing their activity.35,37-39 It may thus prevent fibrosis and 
enhance myofiber formation.40,41  
Different phases of adult myogenesis, including SC differentiation 
and fusion can be regulated through the use of growth factors.42
For instance, hepatocyte growth factor stimulates satellite cell 
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differentiation and angiogenesis.43 However, when growth factors 
are injected in vivo, they rapidly lose their biological activity due to 
diffusion and/or enzymatic inactivation.44 Fortunately, in the last 
years, new biomaterials such as alginate gels have been developed 
that give a controlled release of growth factors over a period of 
time.45,46 These kind of systems may accommodate the long-term 
presence of growth factors in the injured area. Furthermore, a 
specific scaffold geometry may guide the proper alignment of 
differentiating SCs during myofiber formation. This may be 
achieved with topographical cues such as patterning or 
microgrooves, which control cytoskeletal alignment, myotube 
assembly and fusion of differentiating SCs.47,48  
As mentioned earlier (chapter 2 and 6), the specific muscle 
properties related to the cleft may also contribute to the poor 
regeneration of the soft palate muscles after injury. To overcome 
this, cell-based therapy could be used to increase the number of 
SCs in the atrophied cleft palate muscles.49,50 In particular, the 
masseter muscle could serve as an effective source of SCs. 
Unfortunately, the delivery of SCs to injured muscle so far has not 
been very successful.51 SCs cultured and expanded in vitro and then 
transplanted in vivo show a decrease in cell proliferation and in 
myogenic potential.51,52 Other limitations, such as poor survival 
after delivery and tumorigenicity have been reported. Furthermore, 
neonatal SCs that are not able to form long myofibers might limit 
their therapeutic efficacy. Overall, it might be more feasible to 
develop strategies that do not require isolated SCs.  
A potent alternative could be ‘in situ guided tissue regeneration’ 
which aims to recruit resident SCs to the injured area.53,54 The 
combination of a patterned scaffold with growth factors and 
cytokines (e.g., stromal cell derived factor–1) might favor 
migration and differentiation of resident SCs, and induce myofiber 
alignment.34 However, in cases where the availability and quality of 
SCs is limited cell therapy may still be required. 
CHAPTER 7 
 
166
One important aspect not considered in this thesis is the 
interaction between SCs and the local immune response during 
muscle regeneration. Two distinct subpopulations of macrophages 
are sequentially present in injured muscle tissue. Firstly, pro-
inflammatory macrophages secreting pro-inflammatory cytokines 
such as tumor necrosis factor  and interleukin 1, phagocytose the 
necrotic tissue. Secondly, anti-inflammatory macrophages secreting 
anti-inflammatory cytokines resolve inflammation.55 Recent 
research shows that the administration of interleukine-10 to mice 
with dystrophy deactivates the pro-inflammatory macrophages and 
reduce pathology. This suggests that modulation of the 
macrophages population may also improve muscle regeneration.56-
58 
In summary, myofiber formation may be achieved with scaffolds 
of specific design and surface topography. Additionally, 
extracellular matrix components, specific growth factors and/or 
cytokines may limit the development of fibrosis. A better 
understanding of the immune response in injured muscle tissue may 
provide additional targets for therapy.  
 
 
Concluding remarks  
 
It is obvious that new therapies are much needed to improve muscle 
healing and regeneration after cleft palate repair. However, many 
questions remain to be answered. For example, the exact 
contribution of differences in stem cell properties to the poor 
regeneration of branchiomeric muscles is still unclear. Further 
research in this aspect will provide valuable information for clinical 
application in growing patients.  
A key factor to achieve success will not only be to understand 
muscle regeneration in the soft palate muscles under normal 
conditions, but also in cleft muscles. Hence, later studies on SC 
from clefted muscles by using animals with a cleft or transgenic 
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models are warranted. Another important step before translation 
into the clinic will be the use of larger animal models to test 
potential new therapies.  
In this research project, we developed the first animal model for 
muscle regeneration in the soft palate, which can be used to 
investigate and develop new treatment strategies for soft cleft 
palate repair. Next, an innovative method for the isolation and 
culture of SCs was established that allows the study of factors that 
regulate SC differentiation and myotube formation. The results from 
this thesis indicate that not only fibrosis, but also the intrinsic 
characteristics of SCs from BrHM contribute to defective 
regeneration after injury. This research project is the first step into 
the development of novel therapies to improve cleft palate repair 
and the quality of life of patients with CL/P. 
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In chapter 1, the background and rationale of this study is 
explained. Children with a cleft in the soft palate have difficulties 
with speech, swallowing and sucking. These patients are unable to 
separate the nasal from the oral cavity leading to air loss during 
speech. Although surgical repair ameliorates soft palate function by 
joining the clefted muscles of the soft palate, optimal function is in 
some cases not achieved. Adjuvant therapies based on tissue 
engineering might be suitable to improve muscle function after 
surgery Therefore, the aim of this research project was to gain 
knowledge in the understanding of the biology and regeneration of 
branchiomeric head muscles. 
The regeneration of muscles in the soft palate after surgery is 
hampered because of (1) their low intrinsic regenerative capacity, 
(2) the muscle properties related to clefting, and (3) the 
development of fibrosis. Adjuvant strategies based on tissue 
engineering may improve the outcome after surgery by 
approaching these specific issues. In chapter 2 an overview of 
myogenesis in the non-cleft and cleft palate, the characteristics of 
soft palate muscles and the process of muscle regeneration is 
presented. In addition, novel therapeutic strategies based on tissue 
engineering to improve soft palate function after surgical repair are 
proposed. 
In chapter 3, a new in vivo model for the study of muscle 
regeneration in the soft palate of rats is established. This model is 
suitable to study muscle regeneration in the soft palate after 
surgical injury, and allows the development of novel adjuvant 
strategies to promote muscle regeneration. This offers new 
perspectives for the treatment of patients with cleft lip and/or 
palate, and for various other conditions in which the regeneration 
of head muscles is compromised. 
In chapter 4, we study the long–term regeneration of the soft 
palate muscles after excisional injury. Muscle regeneration begins 
with the activation, recruitment and proliferation of satellite cells 
from the wound margins early in wound healing. Howevepr, 
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differentiated myoblasts within the wound fail to form new 
myofibers and large amounts of collagen are deposited in the 
wounded area. Fibrosis as well as defective muscle regeneration 
can hamper the functional recovery of the soft palate muscles after 
cleft palate repair. 
In order to determine whether the intrinsic properties of satellite 
cells from branchiomeric head muscles also contribute to impaired 
muscle regeneration in the soft palate, in vitro culture systems are 
required. Therefore, in chapter 5 a new protocol for the isolation, 
culture and differentiation of satellite cells from head muscles is 
presented. After isolation, low numbers of satellite cells are cultured 
on Matrigel spots of millimeter size to study their differentiation. 
This approach avoids the expansion and passaging of cells. In 
conclusion, this protocol offers new possibilities to study satellite 
cells derived from branchiomeric head muscles or other small 
muscles or muscle samples. 
In chapter 6, the fiber type distribution and the expression of 
satellite cell markers were studied in ex vivo muscle tissue. Next, 
the in vitro differentiation and myotube formation of satellite cells 
isolated from representative muscles originating from the 1st, 2nd
and 4th branchial arches were investigated. This was done with 
satellite cells from neonatal (2-week-old) and young (9-week-old) 
rats to study the effects of age. In this study, we demonstrate that 
not only fibrosis but also the intrinsic properties of satellite cells 
may be responsible for the poor regeneration of the palate muscles 
after (surgical) injury. Moreover neonatal satellite cells appear to 
differentiate less than young satellite cells. 
In chapter 7, the results of the subsequent studies are discussed. 
We developed a model for compromised muscle regeneration in 
the soft palate by introducing a full-thickness defect. This model 
offers promising possibilities for further research. However, in the 
future, the use of larger cleft palate models may be necessary as 
they will approach the clinical situation more closely. We also 
developed a rapid and economical method for the isolation and 
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study of satellite cells derived from head muscles or small muscle 
samples. We confirmed earlier observations that differentiation of 
satellite cells from branchiomeric head muscles is delayed when 
compared with muscles from the limb. This delay in differentiation 
might explain the poor regeneration of branchiomeric head muscles 
in response to injury. We also demonstrated that age-depended 
differences in stem cell properties can determine the regeneration 
of palate muscles after injury.  
Further research on age-dependent differences in stem cell 
properties will provide valuable information for clinical application 
in growing patients. Also, additional studies on satellite cells from 
clefted muscles from transgenic animals with a cleft are warranted. 
In the future, potential new therapies will have to be tested in larger 
animal models. This research project is the first step into the 
development of novel therapies to improve cleft palate repair and 
the quality of life of patients with a cleft in the palate. 
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In hoofdstuk 1, wordt de achtergrond en het belang van deze studie 
beschreven. Kinderen met een aangeboren gespleten gehemelte 
(schisis) hebben moeite met spreken, slikken en zuigen. Deze 
patiënten zijn niet in staat de neus– en mondholte van elkaar te 
scheiden waardoor luchtverlies optreedt tijdens het spreken. 
Ondanks succesvolle sluiting en correctie van de spieren in het 
zachte gehemelte wordt een optimale functie in sommige gevallen 
niet behaald. Adjuvante therapie gebaseerd op tissue engineering 
kan geschikt zijn om de spierfunctie te verbeteren na de operatie. 
Het doel van dit onderzoeksproject is om de biologische processen 
tijdens de regeneratie van spieren van het hoofd beter te begrijpen.
De regeneratie van de spieren in het zachte gehemelte na de 
operatie wordt belemmerd door (1) de lage intrinsieke 
regeneratieve capaciteit, (2) de spiereigenschappen ten gevolge 
van de schisis en (3) de ontwikkeling van fibrose. Adjuvante 
strategieën gebaseerd op tissue engineering kunnen de uitkomst 
na operatie verbeteren door het aanpakken van deze specifieke 
problemen. In hoofdstuk 2 wordt een overzicht van myogenese in 
het niet-gespleten en het gespleten gehemelte gegeven.  De 
kenmerken de spieren in het zachte gehemeltes en het proces van 
spierregeneratie worden gepresenteerd. Bovendien worden 
nieuwe therapeutische strategieën gebaseerd op tissue 
engineering voorgesteld om de functie van het zachte gehemelte 
na chirurgie te verbeteren.   
In hoofdstuk 3 wordt een nieuw in vivo model voor de studie van 
spierregeneratie in het zachte gehemelte van ratten gepresenteerd. 
Dit model is geschikt om spierregeneratie na chirurgisch letsel in 
het zachte gehemelte te bestuderen, en maakt de ontwikkeling van 
nieuwe adjuvante strategieën voor spierregeneratie mogelijk. Dit 
biedt nieuwe perspectieven voor de behandeling van patiënten met 
een aangeboren gespleten lip en/of gehemelte, en voor andere 
aandoeningen waarbij de regeneratie van hoofdspieren is vestoord. 
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In hoofdstuk 4 wordt de lange termijn regeneratie van de spieren 
in het zachte gehemelte bestudeerd na verwonding met behulp van 
in vivo model. Na verwonding begint spierregeneratie met de 
activatie, rekrutering, proliferatie en differentiatie van 
satellietcellen vanuit de wondranden. Echter, gedifferentieerde 
myoblasten in de wond blijken geen nieuwe spiervezels te kunnen 
vormen en grote hoeveelheden collageen worden afgezet in het 
wondgebied. Fibrose en onvolledige spierregeneratie belemmert 
het functioneel herstel van de spieren in het zachte gehemelte na 
chirurgie. 
Om te bepalen of naast fibrose de intrinsieke eigenschappen van 
satellietcellen van de spieren van het hoofd bijdragen aan 
verminderde spierregeneratie zijn er in vitro kweeksystemen 
vereist. Daarom wordt in hoofdstuk 5 een nieuw protocol voor de 
isolatie, kweek, en differentiatie van satellietcellen van de spieren 
van het hoofd ontwikkeld en beschreven. Na isolatie worden kleine 
aantallen satellietcellen gekweekt op Matrigel spots van enkele 
millimeters om hun differentiatie te bestuderen. Deze benadering 
vermijdt de expansie en het doorzetten van cellen. Kortom: dit 
protocol biedt nieuwe mogelijkheden om satellietcellen afkomstig 
van de spieren van het hoofd en ook van andere kleine spieren of 
spiermonsters te bestuderen. 
In hoofdstuk 6, wordt het spiervezeltype en de expressie van 
satellietcellen-markers onderzocht in ex vivo spierweefsel. 
Daarnaast worden de in vitro differentiatie en myotube vorming van 
geïsoleerde satellietcellen uit representatieve spieren afkomstig 
van de 1e, 2e, en 4e kieuwbogen in het hoofd onderzocht. Dit is 
gedaan met satellietcellen van neonatale (2 weken oude) en jonge 
(9 weken oude) ratten om het effect van de leeftijd te bestuderen. 
In deze studie hebben we aangetoond dat niet alleen fibrose maar 
ook de intrinsieke eigenschappen van satellietcellen bijdragen aan 
de slechte regeneratie van de spieren na chirurgisch letsel. 
Bovendien blijken satellietcellen in neonatale spieren minder goed 
te differentiëren dan satellietcellen uit jonge spieren. 
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In hoofdstuk 7 wordt de betekenis van onze resultaten voor 
toekomstige studies besproken. We hebben een model ontwikkeld 
voor verstoorde spierregeneratie in het zachte gehemelte door het 
maken van een excisie wond. Dit model biedt veel mogelijkheden 
voor verder onderzoek. In de toekomst is echter ook onderzoek 
nodig in grotere dieren, omdat dit de klinische situatie beter 
benadert. We hebben ook een nieuwe, snelle en economische 
methode ontwikkeld voor de isolatie en studie van satellietcellen 
afkomstig van de spieren van het hoofd of kleine spier monsters. 
We bevestigen eerdere observaties dat de differentiatie van de 
spieren van het hoofd trager is dan die van de spieren van de 
ledematen. Deze vertraging in differentiatie zou kunnen bijdragen 
aan de gebrekkige regeneratie van de spieren van het hoofd na 
letsel. We hebben ook aangetoond dat de leeftijdsafhankelijke 
verschillen in satelliet celeigenschappen de regeneratie van 
gehemeltespieren beïnvloeden. 
Verder onderzoek naar leeftijdsafhankelijke verschillen in stamcel 
eigenschappen zal waardevolle informatie opleveren voor klinische 
toepassing in groeiende schisis patiënten. Ook aanvullende studies 
aan satellietcellen van spieren van transgene dieren met een 
gespleten gehemelte zijn wenselijk. In de toekomst zullen 
potentiële nieuwe therapieën moeten worden getest in grotere 
diermodellen. Dit onderzoek is de eerste stap naar de ontwikkeling 
van nieuwe therapieën om de functie van het zachte gehemelte en 
de kwaliteit van leven van patiënten met een schisis te verbeteren.  
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